updating data for batch codes
This commit is contained in:
no name
@@ -1 +1 @@
|
||||
{"asthenia": 4.7}
|
||||
{"asthenia": 4.15}
|
||||
@@ -1 +1 @@
|
||||
{"anaemia": 4.25, "ascites": 8.09, "aspartate aminotransferase increased": 2.13, "breast cancer": 2.63, "breast cancer metastatic": 68.82, "cholangitis": 27.72, "colitis": 4.29, "dehydration": 2.99, "disease progression": 3.72, "drug eruption": 3.53, "drug-induced liver injury": 2.78, "febrile neutropenia": 25.2, "hypophagia": 19.46, "immune-mediated enterocolitis": 24.48, "interstitial lung disease": 17.96, "leukopenia": 2.74, "liver disorder": 3.44, "maligt neoplasm progression": 17.43, "metastases to bone": 42.29, "metastases to central nervous system": 9.59, "metastases to liver": 21.92, "metastases to lung": 17.24, "myelosuppression": 7.63, "neoplasm progression": 6.88, "neuropathy peripheral": 9.41, "neutropenia": 5.14, "neutrophil count decreased": 10.32, "off label use": 2.51, "palmar-plantar erythrodysaesthesia syndrome": 3.24, "peripheral sensory neuropathy": 18.17, "pik3ca-activated mutation": 405.54, "pleural effusion": 3.08, "pneumonia": 2.27, "pneumonitis": 13.26, "sepsis": 2.93, "septic shock": 5.6, "stomatitis": 5.37, "thrombocytopenia": 2.92, "white blood cell count decreased": 4.02}
|
||||
{"atrial fibrillation": 6.83, "guillain-barre syndrome": 70.63, "maternal exposure during pregnancy": 40.63, "premature baby": 111.36, "premature delivery": 141.59, "respiratory syncytial virus infection": 49.07}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"asthenia": 2.24, "blood pressure increased": 4.79, "decreased appetite": 2.7, "haemoglobin decreased": 18.87, "haemoglobin increased": 156.8, "hepatic function abnormal": 12.76, "hyperkalaemia": 25.68, "inappropriate schedule of product administration": 12.7, "product use issue": 9.38, "pruritus": 2.05}
|
||||
{"acute graft versus host disease": 11.89, "acute myeloid leukaemia": 18.89, "alanine aminotransferase increased": 2.54, "anaemia": 13.05, "aspartate aminotransferase increased": 2.3, "basal cell carcinoma": 20.01, "bk virus infection": 22.97, "blood bilirubin increased": 2.14, "blood lactate dehydrogenase increased": 8.05, "c-reactive protein increased": 2.53, "chronic graft versus host disease": 27.74, "concomitant disease aggravated": 9.07, "cytomegalovirus infection": 16.35, "cytomegalovirus infection reactivation": 31.96, "cytopenia": 26.23, "disease recurrence": 3.65, "epstein-barr virus infection reactivation": 34.52, "graft versus host disease": 8.07, "haematocrit decreased": 12.27, "haemoglobin abnormal": 22.0, "haemoglobin decreased": 14.32, "infection": 2.43, "leukocytosis": 29.44, "leukopenia": 3.29, "lymphopenia": 4.06, "malignant neoplasm progression": 2.45, "multiple organ dysfunction syndrome": 2.6, "myelofibrosis": 187.7, "neutrophil count increased": 20.86, "night sweats": 2.78, "pancytopenia": 3.93, "platelet count abnormal": 38.28, "platelet count decreased": 11.62, "platelet count increased": 30.54, "pneumonia": 2.36, "primary myelofibrosis": 539.51, "product use in unapproved indication": 23.26, "product use issue": 3.04, "pulmonary tuberculosis": 20.0, "red blood cell count decreased": 5.76, "respiratory failure": 2.9, "second primary malignancy": 132.59, "sepsis": 3.52, "septic shock": 2.52, "skin lesion": 2.92, "spleen disorder": 62.54, "splenomegaly": 112.55, "squamous cell carcinoma": 63.04, "squamous cell carcinoma of skin": 55.52, "therapeutic response decreased": 9.15, "therapy non-responder": 10.94, "therapy partial responder": 21.67, "thrombocytopenia": 13.44, "thrombocytosis": 35.9, "tuberculosis": 12.56, "weight increased": 2.85, "white blood cell count decreased": 2.42, "white blood cell count increased": 16.59, "withdrawal syndrome": 6.33}
|
||||
@@ -1 +1 @@
|
||||
{"blood creatinine increased": 9.54, "cardiac failure": 12.22, "cognitive disorder": 17.57, "constipation": 3.61, "death": 5.45, "disease progression": 5.68, "dizziness": 2.1, "fall": 2.61, "renal impairment": 4.34, "taste disorder": 12.73, "weight increased": 3.88}
|
||||
{"abdominal discomfort": 6.83, "abdominal distension": 7.8, "abdominal pain": 3.29, "abdominal pain upper": 5.94, "acute kidney injury": 3.08, "amylase increased": 6.68, "blood glucose decreased": 2.33, "blood glucose increased": 5.81, "cholecystitis": 8.77, "cholelithiasis": 13.73, "constipation": 9.17, "decreased appetite": 4.33, "dehydration": 4.26, "diabetes mellitus inadequate control": 7.5, "diabetic ketoacidosis": 2.9, "diarrhoea": 3.37, "drug intolerance": 4.28, "dysgeusia": 3.6, "dyspepsia": 11.54, "eructation": 36.3, "feeding disorder": 3.08, "flatulence": 13.87, "gastritis": 4.1, "gastrointestinal disorder": 7.63, "gastrooesophageal reflux disease": 5.9, "glycosylated haemoglobin increased": 25.58, "impaired gastric emptying": 32.02, "inappropriate schedule of product administration": 2.85, "increased appetite": 9.68, "intestinal obstruction": 4.35, "lipase increased": 9.21, "nausea": 3.81, "off label use": 3.55, "pancreatic carcinoma": 5.26, "pancreatitis": 19.4, "pancreatitis acute": 15.33, "product taste abnormal": 27.43, "product use in unapproved indication": 2.24, "suicidal ideation": 2.35, "surgery": 2.86, "taste disorder": 3.39, "vomiting": 5.54, "weight decreased": 4.91, "weight increased": 2.59}
|
||||
@@ -1 +1 @@
|
||||
{"adverse drug reaction": 2.95, "adverse event": 29.18, "alanine aminotransferase increased": 5.62, "anaemia": 7.82, "ascites": 5.2, "aspartate aminotransferase increased": 4.8, "asthenia": 2.02, "blood alkaline phosphatase increased": 2.36, "blood creatinine increased": 8.76, "blood magnesium decreased": 33.47, "blood potassium decreased": 5.63, "blood test abnormal": 10.0, "carbohydrate antigen 125 increased": 764.29, "constipation": 5.2, "death": 3.73, "decreased appetite": 2.88, "dehydration": 5.03, "drug intolerance": 3.94, "dysgeusia": 6.48, "full blood count abnormal": 21.45, "haematocrit decreased": 5.88, "haemoglobin decreased": 8.95, "hepatic enzyme increased": 2.16, "hypophagia": 11.07, "intestinal obstruction": 14.2, "laboratory test abnormal": 14.03, "liver function test abnormal": 3.01, "liver function test increased": 6.69, "maligt neoplasm progression": 18.48, "metastases to central nervous system": 7.32, "myelodysplastic syndrome": 8.14, "neuropathy peripheral": 4.48, "neutropenia": 2.22, "ovarian cancer recurrent": 610.67, "photosensitivity reaction": 5.63, "platelet count decreased": 9.12, "prescribed underdose": 14.06, "product dose omission issue": 8.0, "product use in unapproved indication": 2.07, "recurrent cancer": 39.82, "red blood cell count decreased": 20.12, "renal function test abnormal": 30.16, "renal impairment": 2.72, "small intestinal obstruction": 26.32, "surgery": 3.66, "taste disorder": 4.81, "therapy partial responder": 16.51, "thrombocytopenia": 4.43, "transfusion": 7.89, "tumour marker increased": 26.7, "underdose": 9.67, "urinary tract infection": 2.06, "white blood cell count decreased": 4.9}
|
||||
{"dermatitis acneiform": 130.56, "disease progression": 5.23, "infusion related reaction": 141.81, "non-small cell lung cancer": 210.98, "non-small cell lung cancer metastatic": 1348.13, "paronychia": 330.27, "pneumonitis": 16.93, "rash": 5.35, "skin toxicity": 111.64}
|
||||
@@ -1 +1 @@
|
||||
{"central venous catheterisation": 137.85, "condition aggravated": 4.87, "device related infection": 25.3, "drug ineffective": 3.83, "drug ineffective for unapproved indication": 27.31, "hereditary angioedema": 308.67, "illness": 2.16, "infection": 2.42, "intentional product use issue": 75.87, "kidney infection": 15.0, "laryngeal oedema": 12.51, "maternal exposure during breast feeding": 12.64, "maternal exposure during pregcy": 11.54, "nephrolithiasis": 8.33, "pharyngeal swelling": 109.84, "pneumonia": 2.83, "product dose omission issue": 5.27, "product use in unapproved indication": 9.86, "respiratory tract oedema": 210.82, "sepsis": 5.24, "sinusitis": 6.46, "therapeutic product effect incomplete": 20.46, "thrombosis": 5.27, "underdose": 17.28, "vascular access complication": 934.29, "vascular access site complication": 8914.86, "vascular device infection": 38.85}
|
||||
{"acute myeloid leukaemia": 24.99, "acute myeloid leukaemia recurrent": 161.55, "cardiac failure": 4.44, "cytopenia": 28.29, "death": 2.91, "dysphagia": 4.92, "electrocardiogram qt prolonged": 14.56, "febrile neutropenia": 10.33, "malignant neoplasm progression": 2.63, "neutropenia": 2.75, "platelet count decreased": 2.97, "sepsis": 4.92, "thrombocytopenia": 4.22}
|
||||
@@ -1 +1 @@
|
||||
{"seizure": 19.09}
|
||||
{"alopecia": 11.17, "amenorrhoea": 15.89, "condition aggravated": 6.73, "depressed mood": 8.0, "depression": 5.3, "heavy menstrual bleeding": 11.59, "hot flush": 15.42, "intermenstrual bleeding": 16.2, "irritability": 7.05, "mood swings": 18.32, "uterine haemorrhage": 239.59, "uterine leiomyoma": 119.28, "vaginal haemorrhage": 12.05, "weight increased": 8.41}
|
||||
@@ -1 +1 @@
|
||||
{"antineutrophil cytoplasmic antibody positive": 35.41, "bacterial infection": 3.9, "blood pressure diastolic decreased": 22.38, "blood pressure fluctuation": 41.01, "blood pressure increased": 4.79, "blood pressure systolic increased": 27.87, "body temperature decreased": 7.92, "body temperature fluctuation": 10.24, "c-reactive protein increased": 4.42, "cataract": 4.35, "condition aggravated": 7.65, "cough": 2.25, "covid-19": 2.13, "covid-19 pneumonia": 5.06, "cyst": 4.32, "cystitis": 3.67, "drug effective for unapproved indication": 18.86, "drug ineffective for unapproved indication": 2.95, "dry throat": 3.9, "ear discomfort": 2.66, "ear infection": 3.45, "ear pruritus": 106.56, "eye disorder": 3.57, "eye infection": 4.71, "eye pruritus": 2.6, "flushing": 2.88, "foot deformity": 4.7, "heart rate decreased": 8.72, "heart rate increased": 2.48, "heart rate irregular": 11.33, "hernia": 2.97, "hip arthroplasty": 4.04, "hypertension": 2.75, "illness": 3.09, "immunodeficiency": 3.31, "immunosuppression": 5.96, "inappropriate schedule of product administration": 8.79, "incorrect product administration duration": 13.12, "infection": 3.18, "infusion related reaction": 6.52, "infusion site extravasation": 16.35, "infusion site pain": 7.23, "infusion site swelling": 11.16, "intentional product use issue": 50.62, "joint injury": 6.33, "joint swelling": 2.29, "knee arthroplasty": 3.66, "knee operation": 5.13, "lacrimation increased": 2.26, "limb injury": 4.85, "localised infection": 5.78, "loss of personal independence in daily activities": 2.8, "lower respiratory tract infection": 4.27, "lung disorder": 3.94, "nasal congestion": 3.61, "nasopharyngitis": 3.89, "off label use": 14.89, "oral pruritus": 5.18, "oropharyngeal discomfort": 3.68, "oropharyngeal pain": 2.29, "oxygen saturation decreased": 4.74, "pharyngeal paraesthesia": 22.95, "pharyngeal swelling": 2.74, "pneumonia": 3.01, "pneumonia bacterial": 7.04, "poor venous access": 75.08, "product use issue": 9.65, "productive cough": 3.12, "pulmonary fibrosis": 3.67, "red blood cell sedimentation rate increased": 3.01, "renal disorder": 2.83, "respiratory rate increased": 3.15, "rheumatoid arthritis": 5.19, "rhinorrhoea": 3.04, "sinus disorder": 4.23, "sinusitis": 4.32, "sinusitis bacterial": 51.54, "stress": 2.0, "synovitis": 5.37, "systemic lupus erythematosus": 2.36, "therapeutic product effect incomplete": 3.37, "therapeutic response shortened": 38.25, "throat irritation": 22.77, "throat tightness": 5.83, "tongue pruritus": 9.95, "tooth disorder": 4.77, "tooth extraction": 8.1, "tooth infection": 4.69, "upper limb fracture": 2.38, "vasculitis": 2.84, "viral infection": 2.89, "weight increased": 2.4, "wound": 2.5, "wrist fracture": 3.62}
|
||||
{"blood glucose increased": 19.76, "hyperglycaemia": 30.62, "hypoglycaemia": 51.97}
|
||||
@@ -1 +1 @@
|
||||
{"acute graft versus host disease": 14.17, "acute myeloid leukaemia": 18.92, "alanine aminotransferase increased": 2.18, "anaemia": 13.4, "basal cell carcinoma": 19.78, "bk virus infection": 29.91, "blood lactate dehydrogenase increased": 6.47, "bone pain": 2.14, "c-reactive protein increased": 2.53, "chronic graft versus host disease": 33.4, "concomitant disease aggravated": 10.05, "cytomegalovirus infection": 18.89, "cytomegalovirus infection reactivation": 38.83, "cytopenia": 29.32, "disease recurrence": 4.32, "epstein-barr virus infection reactivation": 43.62, "graft versus host disease": 9.06, "haematocrit decreased": 11.09, "haemoglobin abnormal": 24.3, "haemoglobin decreased": 14.23, "infection": 2.58, "leukocytosis": 21.75, "leukopenia": 2.83, "lymphopenia": 4.65, "maligt neoplasm progression": 3.23, "multiple organ dysfunction syndrome": 2.41, "myelofibrosis": 178.01, "neutrophil count increased": 20.81, "night sweats": 3.18, "pancytopenia": 3.67, "platelet count abnormal": 45.03, "platelet count decreased": 11.56, "platelet count increased": 30.72, "pneumonia": 2.19, "primary myelofibrosis": 656.26, "product use in unapproved indication": 16.4, "product use issue": 2.75, "pulmonary tuberculosis": 22.61, "red blood cell count decreased": 5.54, "respiratory failure": 2.65, "second primary maligcy": 168.74, "sepsis": 3.49, "septic shock": 2.53, "skin lesion": 2.75, "spleen disorder": 59.09, "splenomegaly": 108.66, "squamous cell carcinoma": 61.6, "squamous cell carcinoma of skin": 62.11, "therapeutic response decreased": 8.88, "therapy non-responder": 10.6, "therapy partial responder": 28.35, "thrombocytopenia": 12.64, "thrombocytosis": 31.3, "tuberculosis": 13.86, "weight increased": 2.64, "white blood cell count decreased": 2.2, "white blood cell count increased": 14.48, "withdrawal syndrome": 2.38}
|
||||
{"alopecia": 13.56, "asthenia": 2.94, "constipation": 6.95, "diarrhoea": 6.31, "disease progression": 6.06, "febrile neutropenia": 9.29, "inappropriate schedule of product administration": 4.15, "neutropenia": 22.19}
|
||||
@@ -1 +1 @@
|
||||
{"abdominal discomfort": 6.62, "abdominal distension": 6.89, "abdominal pain": 3.1, "abdominal pain upper": 5.53, "acute kidney injury": 2.2, "amylase increased": 6.09, "blood glucose decreased": 2.54, "blood glucose increased": 6.58, "cholecystitis": 8.78, "cholelithiasis": 12.61, "constipation": 7.65, "decreased appetite": 4.65, "dehydration": 3.85, "diabetes mellitus inadequate control": 8.44, "diabetic ketoacidosis": 3.76, "diarrhoea": 3.43, "drug intolerance": 4.17, "dysgeusia": 3.4, "dyspepsia": 9.91, "eructation": 33.76, "feeding disorder": 3.2, "flatulence": 11.55, "gastritis": 3.61, "gastrointestinal disorder": 7.19, "gastrooesophageal reflux disease": 4.57, "glycosylated haemoglobin increased": 28.96, "hyperglycaemia": 2.16, "impaired gastric emptying": 30.92, "inappropriate schedule of product administration": 3.1, "increased appetite": 8.22, "intestinal obstruction": 3.83, "lipase increased": 9.59, "nausea": 4.29, "off label use": 3.56, "pancreatitis": 20.46, "pancreatitis acute": 14.06, "product taste abnormal": 6.16, "surgery": 2.6, "taste disorder": 3.31, "vomiting": 5.29, "weight decreased": 4.84, "weight increased": 2.39}
|
||||
{"dyskinesia": 99.35, "hallucination": 44.93}
|
||||
@@ -1 +1 @@
|
||||
{"dermatitis acneiform": 149.74, "disease progression": 5.85, "infusion related reaction": 161.42, "non-small cell lung cancer": 281.65, "non-small cell lung cancer metastatic": 1740.17, "paronychia": 418.23, "pneumonitis": 19.99, "rash": 4.77, "skin toxicity": 153.03}
|
||||
{"acute kidney injury": 2.48, "adverse event": 2.51, "alanine aminotransferase increased": 2.9, "altered state of consciousness": 15.12, "anuria": 10.37, "aspartate aminotransferase increased": 4.02, "blood alkaline phosphatase increased": 4.32, "blood bilirubin increased": 6.19, "blood creatine phosphokinase increased": 2.07, "blood creatinine increased": 6.92, "blood potassium decreased": 6.75, "blood potassium increased": 24.77, "blood pressure decreased": 5.28, "blood sodium abnormal": 134.12, "blood sodium decreased": 120.52, "blood sodium increased": 544.93, "blood urea increased": 30.92, "cardiac failure": 9.96, "cardiac failure chronic": 17.98, "cerebral infarction": 5.71, "coma": 2.03, "death": 5.43, "dehydration": 12.92, "delirium": 3.24, "depressed level of consciousness": 3.79, "disseminated intravascular coagulation": 8.96, "drug eruption": 3.13, "drug-induced liver injury": 5.57, "dysphagia": 2.21, "eosinophil count increased": 13.42, "gamma-glutamyltransferase increased": 3.53, "glomerular filtration rate decreased": 7.15, "hepatic cirrhosis": 6.8, "hepatic encephalopathy": 47.08, "hepatic enzyme increased": 2.29, "hepatic failure": 6.25, "hepatic function abnormal": 29.6, "hospice care": 22.41, "hospitalisation": 11.14, "hyperkalaemia": 12.39, "hypernatraemia": 937.93, "hypokalaemia": 4.67, "hyponatraemia": 19.07, "inability to afford medication": 73.42, "inappropriate schedule of product administration": 10.12, "incorrect dose administered": 4.23, "incorrect drug administration rate": 60.6, "incorrect product administration duration": 131.4, "incorrect route of product administration": 6.58, "insurance issue": 40.51, "liver disorder": 12.08, "liver function test abnormal": 2.75, "lung neoplasm malignant": 4.26, "mental status changes": 5.19, "multiple organ dysfunction syndrome": 4.04, "no adverse event": 4.07, "off label use": 2.24, "osmotic demyelination syndrome": 510.77, "pancytopenia": 2.98, "platelet count decreased": 3.39, "pneumonia aspiration": 4.62, "pollakiuria": 2.66, "polyuria": 26.42, "prescribed underdose": 9.67, "product dose omission issue": 3.36, "product use in unapproved indication": 11.49, "rapid correction of hyponatraemia": 41408.24, "renal disorder": 2.88, "renal impairment": 11.55, "shock": 5.05, "therapy interrupted": 6.52, "thirst": 15.94, "underdose": 32.08, "urine output decreased": 8.97, "urine output increased": 41.33, "wrong technique in product usage process": 26.47}
|
||||
@@ -1 +1 @@
|
||||
{"acute myeloid leukaemia": 25.07, "acute myeloid leukaemia recurrent": 173.5, "cardiac failure": 4.53, "cytopenia": 31.69, "death": 2.81, "diarrhoea": 2.0, "dysphagia": 4.23, "electrocardiogram qt prolonged": 9.42, "febrile neutropenia": 11.32, "maligt neoplasm progression": 3.47, "neutropenia": 2.81, "platelet count decreased": 2.95, "sepsis": 4.88, "thrombocytopenia": 3.98}
|
||||
{"nausea": 2.45, "product adhesion issue": 518.21, "vomiting": 2.68}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"alopecia": 11.25, "amenorrhoea": 21.14, "condition aggravated": 6.42, "depressed mood": 7.01, "depression": 4.27, "heavy menstrual bleeding": 16.14, "hot flush": 16.39, "intermenstrual bleeding": 20.57, "irritability": 6.12, "mood swings": 15.42, "uterine haemorrhage": 190.31, "uterine leiomyoma": 93.69, "vaginal haemorrhage": 10.95, "weight increased": 7.79}
|
||||
{"anaphylactic reaction": 5.14, "herpes zoster": 6.18, "hypersensitivity": 3.62, "rash": 2.05, "urticaria": 2.02}
|
||||
@@ -1 +1 @@
|
||||
{"blood glucose increased": 22.38, "hyperglycaemia": 35.29, "hypoglycaemia": 50.74}
|
||||
{"anaemia": 3.96, "disease progression": 13.16, "dyspnoea": 3.08, "infection": 7.6, "infusion related reaction": 77.6, "neutropenia": 11.9, "pneumonia": 5.83, "thrombocytopenia": 5.2}
|
||||
@@ -1 +1 @@
|
||||
{"alopecia": 13.65, "asthenia": 3.33, "constipation": 5.81, "diarrhoea": 6.43, "disease progression": 6.79, "febrile neutropenia": 10.18, "inappropriate schedule of product administration": 4.52, "neutropenia": 22.7}
|
||||
{"drug ineffective": 2.53, "neutropenia": 17.66}
|
||||
@@ -1 +1 @@
|
||||
{"dyskinesia": 69.81, "hallucination": 30.95}
|
||||
{"neuromyelitis optica spectrum disorder": 3219.48, "neutropenia": 6.83, "pneumonia": 3.68}
|
||||
@@ -1 +1 @@
|
||||
{"adverse event": 2.18, "alanine aminotransferase increased": 2.48, "altered state of consciousness": 9.82, "anuria": 6.49, "aspartate aminotransferase increased": 3.35, "blood alkaline phosphatase increased": 3.26, "blood bilirubin increased": 5.58, "blood creatinine increased": 6.24, "blood potassium decreased": 5.48, "blood potassium increased": 20.13, "blood pressure decreased": 3.89, "blood sodium abnormal": 104.28, "blood sodium decreased": 89.6, "blood sodium increased": 395.86, "blood urea increased": 21.4, "cardiac failure": 10.14, "cardiac failure chronic": 17.63, "cardiac failure congestive": 2.17, "cerebral infarction": 6.13, "death": 5.24, "dehydration": 11.66, "delirium": 2.31, "depressed level of consciousness": 2.69, "disseminated intravascular coagulation": 7.1, "drug-induced liver injury": 3.8, "eosinophil count increased": 11.16, "gamma-glutamyltransferase increased": 2.62, "glomerular filtration rate decreased": 8.21, "hepatic cirrhosis": 6.94, "hepatic encephalopathy": 46.37, "hepatic failure": 5.49, "hepatic function abnormal": 20.42, "hospice care": 24.97, "hospitalisation": 10.73, "hyperkalaemia": 6.9, "hypernatraemia": 534.73, "hyponatraemia": 8.67, "inability to afford medication": 46.89, "inappropriate schedule of product administration": 11.02, "incorrect dose administered": 2.26, "incorrect drug administration rate": 37.98, "incorrect product administration duration": 58.69, "incorrect route of product administration": 4.64, "insurance issue": 31.17, "liver disorder": 10.14, "liver function test abnormal": 2.17, "mental status changes": 3.99, "multiple organ dysfunction syndrome": 3.74, "no adverse event": 3.26, "off label use": 2.25, "osmotic demyelination syndrome": 292.21, "pancytopenia": 2.78, "platelet count decreased": 3.37, "pleural effusion": 2.07, "pneumonia aspiration": 3.77, "pollakiuria": 2.38, "polyuria": 22.26, "prescribed underdose": 11.78, "product dose omission issue": 2.98, "product use in unapproved indication": 8.12, "rapid correction of hyponatraemia": 23828.04, "renal disorder": 2.68, "renal impairment": 10.8, "shock": 2.88, "therapy interrupted": 5.59, "thirst": 17.05, "underdose": 26.9, "urine output decreased": 6.73, "urine output increased": 32.86, "wrong technique in product usage process": 18.8}
|
||||
{"off label use": 40.92}
|
||||
@@ -1 +1 @@
|
||||
{"nausea": 2.76, "product adhesion issue": 241.79, "vomiting": 2.56}
|
||||
{"abdominal discomfort": 2.23, "abdominal distension": 6.89, "abdominal pain": 3.41, "abdominal pain upper": 3.92, "abortion spontaneous": 2.33, "amylase increased": 7.2, "appendicitis": 3.35, "appetite disorder": 26.6, "biliary colic": 42.67, "breast cancer": 3.7, "cholecystectomy": 32.29, "cholecystitis": 32.97, "cholecystitis acute": 14.91, "cholelithiasis": 57.21, "constipation": 10.42, "dehydration": 4.15, "depressed mood": 2.32, "depression": 2.39, "depressive symptom": 7.4, "device delivery system issue": 11.88, "device failure": 5.97, "device issue": 2.68, "device malfunction": 6.34, "diarrhoea": 2.82, "diarrhoea haemorrhagic": 3.06, "disability": 4.06, "discomfort": 2.15, "diverticulitis": 4.55, "drug dose titration not performed": 56.43, "drug effect less than expected": 12.62, "dry mouth": 3.24, "dyspepsia": 10.01, "eructation": 42.2, "flatulence": 9.54, "food craving": 63.6, "gallbladder disorder": 8.63, "gastritis": 7.89, "gastroenteritis": 4.25, "gastrooesophageal reflux disease": 7.43, "hepatic steatosis": 3.5, "hunger": 36.03, "hypoglycaemic unconsciousness": 3.48, "impaired gastric emptying": 8.93, "inappropriate schedule of product administration": 2.85, "incorrect dose administered by device": 7.32, "increased appetite": 17.04, "injection site bruising": 16.95, "injection site discolouration": 18.61, "injection site erythema": 5.67, "injection site hypersensitivity": 50.88, "injection site induration": 3.09, "injection site irritation": 33.5, "injection site mass": 7.61, "injection site pruritus": 12.09, "injection site rash": 32.13, "injection site urticaria": 31.73, "intestinal obstruction": 2.93, "lack of satiety": 257.48, "lipase increased": 13.6, "liquid product physical issue": 5.42, "maternal exposure during pregnancy": 2.36, "nausea": 2.9, "nephrolithiasis": 2.89, "pancreatic carcinoma": 3.3, "pancreatitis": 25.87, "pancreatitis acute": 12.9, "pancreatitis necrotising": 11.06, "papillary thyroid cancer": 19.0, "prescription drug used without a prescription": 15.66, "product quality issue": 8.52, "product storage error": 2.26, "product use issue": 2.03, "skin reaction": 2.12, "suicidal ideation": 5.39, "surgery": 4.78, "suspected counterfeit product": 10.92, "therapeutic product effect decreased": 2.31, "thyroid cancer": 13.75, "thyroid mass": 16.7, "vomiting": 3.77, "weight increased": 4.43, "weight loss poor": 703.63, "wrong technique in product usage process": 3.76}
|
||||
@@ -1 +1 @@
|
||||
{"anaphylactic reaction": 3.69, "herpes zoster": 7.71, "hypersensitivity": 2.72}
|
||||
{"platelet count decreased": 8.01, "thrombocytopenia": 14.32}
|
||||
@@ -1 +1 @@
|
||||
{"anaemia": 4.07, "disease progression": 14.74, "dyspnoea": 2.96, "infection": 8.07, "infusion related reaction": 88.39, "neutropenia": 12.18, "pneumonia": 5.42, "thrombocytopenia": 4.9}
|
||||
{"alanine aminotransferase increased": 8.59, "ascites": 4.85, "aspartate aminotransferase increased": 11.26, "asthenia": 2.01, "blood bilirubin increased": 4.69, "blood creatine phosphokinase increased": 162.48, "blood creatine phosphokinase mb increased": 347.92, "blood creatinine increased": 2.15, "blood lactate dehydrogenase increased": 36.11, "blood lactic acid increased": 122.06, "blood uric acid increased": 35.29, "dysstasia": 7.59, "exposure during pregnancy": 3.86, "foetal exposure during pregnancy": 7.95, "gait disturbance": 5.6, "hepatic cirrhosis": 32.88, "hepatic function abnormal": 2.41, "hepatitis": 4.32, "hepatitis b": 52.92, "hepatitis b dna increased": 102.67, "hepatitis b surface antigen positive": 274.5, "hypoaesthesia": 3.43, "jaundice": 6.54, "lactic acidosis": 49.12, "liver function test abnormal": 5.47, "maternal exposure during pregnancy": 2.64, "metabolic acidosis": 12.28, "multiple organ dysfunction syndrome": 4.03, "muscle atrophy": 22.96, "muscular weakness": 11.6, "myoglobin blood increased": 481.51, "myopathy": 125.48, "myositis": 22.5, "neuropathy peripheral": 7.66, "oedema peripheral": 4.18, "rhabdomyolysis": 28.98}
|
||||
@@ -1 +1 @@
|
||||
{"drug ineffective": 2.41, "neutropenia": 18.07}
|
||||
{"angioedema": 2.48, "asphyxia": 26.16, "asthma": 10.04, "atrial fibrillation": 3.2, "bronchospasm": 16.58, "bronchospasm paradoxical": 535.42, "chest discomfort": 3.93, "chronic obstructive pulmonary disease": 30.38, "cough": 5.74, "device malfunction": 12.79, "dry mouth": 10.38, "dysphonia": 5.77, "dyspnoea": 4.06, "dysuria": 8.21, "epistaxis": 2.62, "glaucoma": 10.49, "hyperglycaemia": 2.16, "incorrect dose administered": 5.95, "incorrect route of product administration": 38.49, "lip swelling": 3.59, "lung disorder": 4.01, "pneumonia": 2.86, "product use in unapproved indication": 4.35, "productive cough": 10.93, "swelling face": 2.59, "swollen tongue": 6.36, "throat irritation": 8.27, "urinary retention": 18.03, "vision blurred": 2.35, "wheezing": 8.52, "wrong technique in product usage process": 4.96}
|
||||
@@ -1 +1 @@
|
||||
{"neuromyelitis optica spectrum disorder": 4131.56, "neutropenia": 6.99, "pneumonia": 3.43}
|
||||
{"aggression": 6.98, "agitation": 11.34, "amnesia": 3.51, "anxiety": 4.68, "balance disorder": 2.03, "coma": 3.75, "confusional state": 6.0, "contraindicated product administered": 28.51, "delirium": 3.55, "depressed level of consciousness": 2.74, "disorientation": 3.16, "dissociation": 54.67, "dizziness": 2.14, "drug interaction": 4.32, "drug withdrawal syndrome": 50.62, "dry mouth": 5.86, "dysarthria": 2.98, "dyskinesia": 6.2, "euphoric mood": 30.72, "feeling abnormal": 6.73, "feeling drunk": 24.68, "hallucination": 14.05, "hallucination, auditory": 23.09, "hallucination, visual": 28.4, "hyperhidrosis": 4.84, "insomnia": 7.14, "irritability": 2.49, "muscle spasms": 5.68, "nausea": 2.06, "nightmare": 4.87, "overdose": 2.15, "priapism": 39.41, "product dispensing error": 18.29, "psychotic disorder": 6.87, "restlessness": 6.88, "sleep disorder": 4.62, "somnolence": 3.04, "suicidal ideation": 6.38, "tremor": 5.56, "vertigo": 6.85, "vomiting": 2.21, "withdrawal syndrome": 77.7, "wrong technique in product usage process": 5.43}
|
||||
@@ -1 +1 @@
|
||||
{"abdominal abscess": 7.52, "abscess": 2.48, "acute myeloid leukaemia": 2.72, "age-related macular degeneration": 24.2, "anaemia": 2.59, "anal fistula": 13.26, "anaphylactic shock": 2.27, "anaphylactoid reaction": 4.46, "ascites": 4.43, "blindness": 4.66, "blindness transient": 4.92, "blindness unilateral": 5.19, "bone marrow failure": 2.04, "brain oedema": 3.56, "carcinoembryonic antigen increased": 14.3, "cardiac failure": 2.89, "cardiomyopathy": 3.05, "cerebral infarction": 3.33, "cerebral ischaemia": 4.03, "choroidal neovascularisation": 12.28, "colitis ischaemic": 3.62, "colon cancer": 3.28, "colon cancer metastatic": 35.13, "colorectal cancer metastatic": 24.48, "constipation": 2.3, "cytopenia": 2.85, "decreased appetite": 2.2, "deep vein thrombosis": 2.73, "dehydration": 2.38, "dermatitis acneiform": 3.96, "detachment of retinal pigment epithelium": 23.97, "device related infection": 4.51, "diabetic retinal oedema": 40.42, "diabetic retinopathy": 3.9, "diarrhoea": 2.31, "disease progression": 20.4, "disseminated intravascular coagulation": 8.66, "dry age-related macular degeneration": 27.3, "dry throat": 2.47, "duodenal perforation": 41.01, "duodenal ulcer": 3.26, "duodenal ulcer haemorrhage": 4.5, "duodenal ulcer perforation": 5.19, "ejection fraction decreased": 4.45, "embolism": 5.05, "embolism venous": 10.06, "endophthalmitis": 12.13, "enteritis": 4.54, "enterocolitis": 5.89, "enterocutaneous fistula": 55.35, "epistaxis": 2.89, "eye discharge": 8.78, "eye disorder": 2.32, "eye haemorrhage": 9.9, "eye infection": 3.11, "eye inflammation": 4.03, "eye irritation": 2.2, "eye pain": 2.15, "febrile neutropenia": 6.94, "female genital tract fistula": 37.5, "fistula": 14.12, "fournier's gangrene": 5.01, "gastric haemorrhage": 2.58, "gastric perforation": 29.82, "gastric ulcer": 4.5, "gastric ulcer haemorrhage": 2.46, "gastrointestinal necrosis": 9.75, "gastrointestinal perforation": 86.51, "gastrointestinal toxicity": 12.69, "granulocyte count decreased": 13.13, "haematotoxicity": 5.67, "haemoglobin decreased": 2.08, "haemoptysis": 2.77, "haemorrhage": 2.46, "hiccups": 3.74, "hydronephrosis": 4.1, "hyperammonaemia": 12.09, "hypertension": 3.53, "hypoalbuminaemia": 2.69, "hypomagnesaemia": 3.05, "ileal perforation": 71.89, "ileus": 9.95, "impaired healing": 6.37, "infusion related reaction": 2.82, "intentional product use issue": 4.58, "interstitial lung disease": 6.86, "intestinal obstruction": 8.14, "intestinal perforation": 20.81, "intraocular pressure increased": 6.43, "large intestine perforation": 43.06, "left ventricular dysfunction": 4.44, "leukoencephalopathy": 7.82, "leukopenia": 2.71, "macular oedema": 23.7, "maligt neoplasm progression": 3.69, "metastases to bone": 3.29, "metastases to central nervous system": 4.97, "metastases to liver": 6.31, "metastases to lung": 8.69, "metastases to lymph nodes": 4.48, "metastases to peritoneum": 9.08, "metastasis": 4.73, "mucosal inflammation": 6.49, "myelosuppression": 10.2, "myocardial ischaemia": 2.06, "necrotising fasciitis": 9.76, "neoplasm": 2.5, "neoplasm progression": 3.85, "neovascular age-related macular degeneration": 15.91, "nephrotic syndrome": 6.93, "neuropathy peripheral": 10.45, "neurotoxicity": 8.55, "neutropenia": 6.13, "neutropenic sepsis": 4.1, "neutrophil count decreased": 15.07, "ocular hyperaemia": 2.82, "ocular hypertension": 13.81, "osteonecrosis of jaw": 5.64, "ovarian cancer": 2.08, "palmar-plantar erythrodysaesthesia syndrome": 10.08, "pancytopenia": 2.13, "peripheral sensory neuropathy": 9.45, "peritoneal disorder": 58.38, "peritonitis": 18.56, "pharyngeal oedema": 3.48, "photopsia": 4.76, "pigmentation disorder": 2.89, "platelet count decreased": 5.14, "portal hypertension": 9.88, "portal vein thrombosis": 5.73, "posterior reversible encephalopathy syndrome": 9.12, "protein urine": 18.66, "protein urine present": 6.79, "proteinuria": 18.35, "pulmonary artery thrombosis": 22.84, "pulmonary embolism": 3.53, "rectal cancer": 5.57, "rectal haemorrhage": 4.02, "rectal perforation": 157.82, "retinal detachment": 3.62, "retinal haemorrhage": 5.96, "retinal oedema": 17.15, "sepsis": 2.36, "septic shock": 2.46, "shock": 3.07, "shock haemorrhagic": 2.45, "small intestinal perforation": 38.09, "splenomegaly": 2.86, "stoma site haemorrhage": 46.27, "stomatitis": 6.3, "subileus": 11.6, "subretinal fluid": 18.87, "suture rupture": 66.53, "therapy partial responder": 3.22, "thrombocytopenia": 3.57, "thrombotic microangiopathy": 3.74, "tumour haemorrhage": 16.39, "tumour marker increased": 4.3, "tumour perforation": 57.04, "uveitis": 2.45, "varices oesophageal": 11.72, "vena cava thrombosis": 11.52, "venous thrombosis": 7.42, "venous thrombosis limb": 5.09, "visual acuity reduced": 8.72, "visual field defect": 3.91, "visual impairment": 2.55, "vitreous floaters": 8.29, "vitreous haemorrhage": 9.19, "vitritis": 5.66, "white blood cell count decreased": 7.01, "wound dehiscence": 19.26, "wound infection": 9.28}
|
||||
{"off label use": 5.09}
|
||||
@@ -1 +1 @@
|
||||
{"off label use": 41.07}
|
||||
{"acute kidney injury": 3.94, "constipation": 3.94, "hyperhidrosis": 2.08, "hypotension": 7.53, "loss of consciousness": 5.2, "muscle spasms": 3.73, "sleep disorder": 6.31, "weight decreased": 2.47}
|
||||
@@ -1 +1 @@
|
||||
{"abdominal discomfort": 2.16, "abdominal distension": 6.09, "abdominal pain": 3.21, "abdominal pain upper": 3.66, "abortion spontaneous": 2.09, "amylase increased": 6.56, "appendicitis": 3.89, "appetite disorder": 26.03, "biliary colic": 38.71, "cholecystectomy": 26.72, "cholecystitis": 32.76, "cholecystitis acute": 15.0, "cholelithiasis": 51.67, "constipation": 8.67, "dehydration": 3.75, "depressed mood": 2.03, "depressive symptom": 6.53, "device delivery system issue": 7.43, "device failure": 3.28, "device issue": 2.54, "device malfunction": 4.32, "diarrhoea": 2.87, "diarrhoea haemorrhagic": 2.81, "disability": 2.5, "discomfort": 2.19, "diverticulitis": 3.8, "drug dose titration not performed": 52.62, "drug effect less than expected": 9.91, "dry mouth": 2.39, "dyspepsia": 8.58, "eructation": 38.95, "flatulence": 7.93, "food craving": 60.16, "gallbladder disorder": 7.35, "gastritis": 6.93, "gastroenteritis": 4.2, "gastrooesophageal reflux disease": 5.75, "hepatic steatosis": 3.21, "hunger": 36.14, "hypoglycaemic unconsciousness": 4.02, "impaired gastric emptying": 8.64, "inappropriate schedule of product administration": 3.11, "incorrect dose administered by device": 6.74, "increased appetite": 14.42, "injection site bruising": 15.83, "injection site discolouration": 20.0, "injection site erythema": 7.55, "injection site haematoma": 2.27, "injection site hypersensitivity": 63.85, "injection site induration": 3.96, "injection site irritation": 34.19, "injection site mass": 9.08, "injection site pruritus": 16.23, "injection site rash": 38.59, "injection site reaction": 2.28, "injection site swelling": 2.12, "injection site urticaria": 34.33, "intestinal obstruction": 2.58, "lack of satiety": 230.78, "lipase increased": 14.14, "liquid product physical issue": 6.26, "liver function test increased": 2.01, "maternal exposure during pregcy": 2.26, "nausea": 3.26, "nephrolithiasis": 2.67, "pancreatitis": 27.19, "pancreatitis acute": 11.82, "pancreatitis necrotising": 10.93, "papillary thyroid cancer": 19.89, "prescription drug used without a prescription": 8.72, "product quality issue": 4.5, "product storage error": 2.24, "suicidal ideation": 3.95, "surgery": 4.35, "suspected counterfeit product": 7.48, "therapeutic product effect decreased": 2.13, "thyroid cancer": 2.96, "thyroid mass": 16.42, "vomiting": 3.6, "weight increased": 4.1, "weight loss poor": 719.29, "wrong technique in product usage process": 2.68}
|
||||
{"blood glucose increased": 9.3, "device defective": 390.05, "device issue": 215.16, "device mechanical issue": 4048.39, "lipodystrophy acquired": 532.77}
|
||||
@@ -1 +1 @@
|
||||
{"platelet count decreased": 7.98, "thrombocytopenia": 13.48}
|
||||
{"dyspareunia": 1508.66, "endometrial thickening": 988.31, "hot flush": 57.26, "muscle spasms": 6.46, "vaginal haemorrhage": 37.37, "vulvovaginal discomfort": 993.98, "vulvovaginal dryness": 691.18, "vulvovaginal pain": 468.76, "vulvovaginal pruritus": 426.29}
|
||||
@@ -1 +1 @@
|
||||
{"alanine aminotransferase increased": 7.37, "ascites": 5.24, "aspartate aminotransferase increased": 9.37, "asthenia": 2.28, "blood bilirubin increased": 4.24, "blood creatine phosphokinase increased": 109.67, "blood creatine phosphokinase mb increased": 286.86, "blood lactate dehydrogenase increased": 28.96, "blood lactic acid increased": 84.69, "blood uric acid increased": 30.41, "chest discomfort": 2.04, "dysstasia": 7.48, "exposure during pregcy": 2.58, "foetal exposure during pregcy": 3.54, "gait disturbance": 5.34, "hepatic cirrhosis": 33.5, "hepatitis": 3.27, "hepatitis b": 56.11, "hepatitis b dna increased": 143.68, "hepatitis b surface antigen positive": 288.76, "hypoaesthesia": 3.98, "jaundice": 4.45, "lactic acidosis": 19.38, "liver function test abnormal": 4.31, "maternal exposure during pregcy": 2.52, "metabolic acidosis": 7.37, "multiple organ dysfunction syndrome": 3.73, "muscle atrophy": 19.52, "muscular weakness": 12.17, "myalgia": 2.39, "myoglobin blood increased": 293.65, "myopathy": 76.09, "myositis": 24.41, "neuropathy peripheral": 7.12, "oedema peripheral": 3.82, "rhabdomyolysis": 16.58}
|
||||
{"completed suicide": 51.87, "depression": 7.72, "drug interaction": 10.37, "serotonin syndrome": 68.38}
|
||||
@@ -1 +1 @@
|
||||
{"asphyxia": 15.52, "asthma": 8.08, "atrial fibrillation": 3.15, "bronchospasm": 9.01, "bronchospasm paradoxical": 221.66, "cardiac failure": 2.02, "chest discomfort": 4.14, "chest pain": 2.04, "chronic obstructive pulmonary disease": 22.67, "cough": 5.66, "device malfunction": 8.72, "dry mouth": 7.64, "dysphonia": 4.82, "dyspnoea": 3.89, "dysuria": 6.65, "epistaxis": 2.59, "glaucoma": 7.9, "hyperglycaemia": 2.49, "incorrect dose administered": 3.18, "incorrect route of product administration": 27.11, "lip swelling": 2.71, "lung disorder": 3.77, "oropharyngeal pain": 2.1, "pneumonia": 2.66, "product use in unapproved indication": 3.08, "productive cough": 11.22, "swelling face": 2.16, "swollen tongue": 4.81, "throat irritation": 5.86, "urinary retention": 11.95, "vision blurred": 2.32, "wheezing": 7.61, "wrong technique in product usage process": 3.54}
|
||||
{"drug interaction": 19.9}
|
||||
@@ -1 +1 @@
|
||||
{"aggression": 4.28, "agitation": 7.41, "amnesia": 2.85, "anxiety": 3.82, "confusional state": 4.7, "contraindicated product administered": 28.04, "delirium": 2.53, "disorientation": 2.45, "dissociation": 46.81, "dizziness": 2.35, "drug interaction": 2.89, "drug withdrawal syndrome": 38.53, "dry mouth": 4.32, "dysarthria": 2.31, "dyskinesia": 4.36, "euphoric mood": 18.36, "feeling abnormal": 6.24, "feeling drunk": 20.26, "hallucination": 9.66, "hallucination, auditory": 16.79, "hallucination, visual": 18.64, "hyperhidrosis": 4.89, "insomnia": 6.84, "irritability": 2.16, "muscle spasms": 5.48, "nausea": 2.32, "nightmare": 3.43, "priapism": 33.25, "product dispensing error": 10.33, "psychotic disorder": 4.89, "restlessness": 5.25, "sleep disorder": 4.4, "somnolence": 2.51, "suicidal ideation": 4.69, "tremor": 4.9, "vertigo": 7.05, "vomiting": 2.11, "withdrawal syndrome": 28.89, "wrong technique in product usage process": 3.88}
|
||||
{"acute disseminated encephalomyelitis": 2.47, "adverse reaction": 3.4, "allodynia": 4.47, "areflexia": 3.55, "bedridden": 7.05, "bell's palsy": 4.1, "blister": 14.62, "burning sensation": 3.31, "cellulitis": 4.34, "coronavirus infection": 3.05, "deafness unilateral": 2.02, "demyelinating polyneuropathy": 5.02, "demyelination": 2.22, "dermatitis bullous": 2.77, "diplegia": 2.0, "discomfort": 2.52, "disease prodromal stage": 197.59, "dysaesthesia": 2.33, "encephalitis": 2.99, "erythema": 4.54, "erythema of eyelid": 2.24, "extra dose administered": 5.18, "facial pain": 3.73, "facial paralysis": 2.08, "genital herpes": 3.0, "genital herpes zoster": 17.83, "genital rash": 6.04, "giant cell arteritis": 2.25, "groin pain": 2.05, "guillain-barre syndrome": 9.12, "herpes ophthalmic": 13.21, "herpes simplex": 7.81, "herpes virus infection": 6.29, "herpes zoster": 30.55, "herpes zoster cutaneous disseminated": 26.31, "herpes zoster disseminated": 7.49, "herpes zoster oticus": 22.41, "herpes zoster reactivation": 17.31, "hyperaesthesia": 8.15, "hyporeflexia": 2.37, "immobile": 5.27, "impaired driving ability": 2.23, "inappropriate schedule of product administration": 2.17, "incomplete course of vaccination": 68.99, "incorrect route of product administration": 6.06, "induration": 4.82, "injected limb mobility decreased": 5.76, "injection site cellulitis": 5.88, "injection site discolouration": 3.92, "injection site erythema": 3.48, "injection site paraesthesia": 2.16, "injection site rash": 4.08, "injection site swelling": 2.24, "injection site vesicles": 13.65, "lip blister": 8.09, "local reaction": 11.8, "loss of personal independence in daily activities": 3.41, "lyme disease": 2.48, "lymphangitis": 4.13, "mobility decreased": 3.6, "monoplegia": 2.77, "myelitis transverse": 2.6, "near death experience": 3.21, "nerve injury": 4.14, "neuralgia": 7.52, "neuralgic amyotrophy": 3.74, "neuritis": 4.12, "ophthalmic herpes simplex": 17.58, "ophthalmic herpes zoster": 28.41, "oral herpes": 7.13, "oral mucosal blistering": 4.11, "pain": 2.85, "pain in extremity": 2.14, "pain of skin": 5.97, "paralysis": 2.64, "peripheral swelling": 2.13, "peripheral vascular disorder": 3.1, "polymyalgia rheumatica": 3.59, "post herpetic neuralgia": 30.85, "product administered at inappropriate site": 5.49, "product administered to patient of inappropriate age": 21.23, "product administration error": 2.27, "product complaint": 2.03, "product supply issue": 14.72, "pruritus": 2.74, "pustule": 7.9, "radiculopathy": 2.92, "rash": 3.14, "rash erythematous": 2.48, "rash macular": 2.14, "rash papular": 3.38, "rash pruritic": 2.67, "rash pustular": 7.3, "rash vesicular": 42.18, "scab": 9.39, "scar": 5.08, "skin irritation": 2.21, "skin lesion": 4.5, "skin warm": 6.27, "social problem": 6.73, "swelling": 2.55, "trigeminal neuralgia": 3.31, "vaccination failure": 4.94, "vaccination site inflammation": 3.55, "vaccination site joint swelling": 2.3, "vaccination site warmth": 2.26, "varicella": 9.99, "varicella zoster virus infection": 9.9, "walking aid user": 2.49}
|
||||
@@ -1 +1 @@
|
||||
{"acute kidney injury": 2.81, "constipation": 3.29, "hyperhidrosis": 2.1, "hypotension": 5.27, "loss of consciousness": 4.49, "muscle spasms": 3.6, "sleep disorder": 6.01, "weight decreased": 2.43}
|
||||
{"abnormal behaviour": 5.78, "abnormal dreams": 7.14, "aggression": 8.95, "agitation": 6.31, "altered state of consciousness": 2.9, "amnesia": 2.11, "behaviour disorder": 28.21, "blood creatine phosphokinase increased": 2.27, "bulimia nervosa": 242.57, "cardiac failure": 2.45, "circulatory collapse": 3.35, "coma": 2.83, "compulsive shopping": 904.43, "condition aggravated": 2.25, "confusional state": 5.49, "constipation": 3.15, "delirium": 7.8, "delusion": 9.28, "dependence": 84.97, "depression": 2.6, "diplopia": 3.78, "drug dependence": 4.57, "dry mouth": 2.33, "dyskinesia": 16.4, "eating disorder": 10.04, "fall": 2.66, "gambling": 393.44, "gambling disorder": 1294.21, "hallucination": 26.8, "hallucination, auditory": 11.84, "hallucination, visual": 35.27, "hyperkinesia": 86.18, "hypersexuality": 460.62, "hyponatraemia": 2.58, "impulse-control disorder": 637.71, "insomnia": 3.64, "libido increased": 85.85, "mania": 11.24, "medication error": 6.94, "mental disorder": 5.25, "muscle rigidity": 6.89, "nightmare": 4.3, "obsessive-compulsive disorder": 37.62, "oedema": 2.24, "oedema peripheral": 7.16, "orthostatic hypotension": 8.97, "overdose": 5.91, "paranoia": 9.4, "parkinson's disease": 16.55, "parkinsonism": 19.54, "personality change": 21.43, "product residue present": 27.26, "psychomotor hyperactivity": 31.32, "psychotic disorder": 7.83, "restless legs syndrome": 23.97, "restlessness": 4.58, "rhabdomyolysis": 3.93, "road traffic accident": 8.29, "sleep attacks": 121.56, "sleep disorder": 5.87, "somnolence": 5.4, "stereotypy": 189.98, "sudden onset of sleep": 137.35, "suicidal ideation": 2.57, "suicide attempt": 9.32, "therapeutic product effect decreased": 2.46, "tremor": 2.59, "weight increased": 3.34, "withdrawal syndrome": 11.32}
|
||||
@@ -1 +1 @@
|
||||
{"blood glucose increased": 10.53, "device defective": 329.15, "device issue": 203.05, "device mechanical issue": 3155.85, "lipodystrophy acquired": 718.04}
|
||||
{"abdominal pain": 2.11, "blood glucose increased": 7.16, "diabetes mellitus": 37.57, "diarrhoea": 2.73, "electrocardiogram qt prolonged": 14.97, "glycosylated haemoglobin increased": 29.92, "hyperglycaemia": 51.45, "product use in unapproved indication": 4.48, "weight decreased": 3.25}
|
||||
@@ -1 +1 @@
|
||||
{"dyspareunia": 809.82, "endometrial thickening": 700.88, "hot flush": 60.83, "muscle spasms": 6.22, "vaginal haemorrhage": 33.94, "vulvovaginal discomfort": 303.28, "vulvovaginal dryness": 379.01, "vulvovaginal pain": 247.21, "vulvovaginal pruritus": 251.27}
|
||||
{"accidental overdose": 96.57, "anaemia": 10.41, "neutropenia": 22.08, "pancytopenia": 66.15, "thrombocytopenia": 23.58}
|
||||
@@ -1 +1 @@
|
||||
{"completed suicide": 21.74, "depression": 6.22, "drug interaction": 6.93, "serotonin syndrome": 33.28}
|
||||
{"acute myocardial infarction": 5.43, "ascites": 2.11, "blindness": 3.33, "blindness unilateral": 2.72, "blood potassium decreased": 3.27, "blood pressure decreased": 3.41, "bradycardia": 2.45, "cardiac arrest": 3.26, "cardiac failure": 2.64, "cardio-respiratory arrest": 3.1, "cardiogenic shock": 4.29, "cerebral haemorrhage": 2.43, "chronic obstructive pulmonary disease": 2.32, "circulatory collapse": 3.66, "completed suicide": 5.77, "condition aggravated": 2.25, "drug abuse": 6.3, "drug ineffective for unapproved indication": 3.29, "drug interaction": 3.86, "dyschromatopsia": 31.34, "dyspepsia": 3.81, "dyspnoea": 2.0, "dyspnoea exertional": 3.3, "erectile dysfunction": 11.96, "erection increased": 16.6, "eye haemorrhage": 3.12, "fluid retention": 6.71, "flushing": 6.37, "foetal exposure during pregnancy": 4.71, "gastrooesophageal reflux disease": 2.27, "generalised tonic-clonic seizure": 4.05, "haemodynamic instability": 11.52, "haemoptysis": 3.34, "hypervolaemia": 9.27, "hypoacusis": 2.55, "hypotension": 5.3, "hypoxia": 5.79, "intentional overdose": 2.65, "intentional product misuse": 5.16, "ischaemic stroke": 3.83, "malignant melanoma": 7.73, "maternal exposure during pregnancy": 2.4, "nasal congestion": 5.69, "oedema": 3.65, "off label use": 2.07, "optic ischaemic neuropathy": 93.98, "overdose": 3.23, "oxygen saturation decreased": 5.81, "pain in jaw": 7.72, "penile pain": 27.56, "pericardial effusion": 2.37, "premature baby": 12.81, "premature delivery": 23.52, "prescription drug used without a prescription": 31.12, "priapism": 61.65, "product contamination": 152.17, "product counterfeit": 89.55, "product substitution issue": 13.85, "product use issue": 4.45, "pulmonary arterial hypertension": 24.35, "pulmonary arterial pressure increased": 46.12, "pulmonary hypertension": 20.32, "pulmonary oedema": 6.42, "respiratory arrest": 4.07, "respiratory failure": 2.36, "retinal vein occlusion": 5.89, "right ventricular failure": 29.82, "self-medication": 65.59, "subarachnoid haemorrhage": 5.82, "sudden death": 2.73, "therapeutic product effect incomplete": 2.06, "therapeutic response unexpected": 2.27, "toxicity to various agents": 4.99, "transient global amnesia": 29.97, "ventricular tachycardia": 4.21, "vision blurred": 2.72, "visual acuity reduced": 3.04, "visual field defect": 7.95, "visual impairment": 2.23}
|
||||
@@ -1 +1 @@
|
||||
{"off label use": 5.11}
|
||||
{"alanine aminotransferase increased": 3.25, "anaemia": 2.25, "arthritis": 3.64, "dehydration": 2.58, "diarrhoea": 2.89, "disease progression": 26.08, "dysphonia": 10.03, "febrile neutropenia": 9.69, "general physical health deterioration": 4.13, "hepatitis": 6.65, "hypertension": 5.62, "hyperthyroidism": 18.77, "hypothyroidism": 28.14, "infusion related reaction": 26.54, "mucosal inflammation": 10.59, "myocarditis": 4.36, "myositis": 18.55, "neoplasm progression": 20.93, "off label use": 4.02, "pneumonitis": 7.04, "sepsis": 2.43, "thrombocytopenia": 2.69}
|
||||
@@ -1 +1 @@
|
||||
{"drug interaction": 13.3}
|
||||
{"anogenital warts": 275.18, "cervical dysplasia": 202.97, "loss of consciousness": 3.54, "muscular weakness": 3.15, "papilloma viral infection": 254.25, "seizure": 2.77, "syncope": 5.06, "urticaria": 2.34, "vertigo": 5.54}
|
||||
@@ -1 +1 @@
|
||||
{"acute disseminated encephalomyelitis": 2.79, "adverse reaction": 3.17, "allodynia": 5.09, "areflexia": 2.66, "bedridden": 7.91, "bell's palsy": 5.62, "blister": 11.74, "burning sensation": 3.2, "cellulitis": 4.52, "coronavirus infection": 3.46, "deafness unilateral": 2.32, "demyelinating polyneuropathy": 5.81, "demyelination": 2.54, "diplegia": 2.09, "discomfort": 2.56, "disease prodromal stage": 210.95, "dysaesthesia": 2.55, "encephalitis": 3.14, "erysipelas": 2.06, "erythema": 3.58, "extensive swelling of vaccinated limb": 2.45, "extra dose administered": 4.23, "facial pain": 4.35, "facial paralysis": 2.59, "facial paresis": 2.32, "genital herpes": 3.87, "genital herpes zoster": 23.41, "genital rash": 5.36, "giant cell arteritis": 2.84, "groin pain": 2.33, "guillain-barre syndrome": 11.55, "herpes ophthalmic": 15.94, "herpes simplex": 9.29, "herpes virus infection": 7.64, "herpes zoster": 37.46, "herpes zoster cutaneous disseminated": 34.63, "herpes zoster disseminated": 9.56, "herpes zoster oticus": 28.53, "herpes zoster reactivation": 24.37, "hyperaesthesia": 9.27, "immobile": 4.96, "inappropriate schedule of product administration": 2.36, "incomplete course of vaccination": 78.43, "incorrect route of product administration": 4.23, "induration": 5.55, "influenza like illness": 2.17, "injected limb mobility decreased": 8.02, "injection site cellulitis": 5.38, "injection site discolouration": 4.21, "injection site discomfort": 2.31, "injection site erythema": 4.64, "injection site induration": 2.08, "injection site pain": 2.13, "injection site paraesthesia": 2.72, "injection site rash": 4.91, "injection site swelling": 3.09, "injection site vesicles": 13.24, "injection site warmth": 2.06, "lip blister": 6.69, "local reaction": 14.36, "loss of personal independence in daily activities": 3.6, "lyme disease": 2.64, "lymphangitis": 4.45, "mobility decreased": 4.24, "monoplegia": 3.03, "myelitis transverse": 3.29, "near death experience": 2.35, "nerve injury": 3.88, "neuralgia": 9.5, "neuralgic amyotrophy": 4.99, "neuritis": 4.99, "ophthalmic herpes simplex": 20.24, "ophthalmic herpes zoster": 36.11, "oral herpes": 9.33, "oral mucosal blistering": 3.41, "pain": 3.29, "pain in extremity": 2.77, "pain of skin": 6.95, "paralysis": 2.56, "peripheral swelling": 2.38, "peripheral vascular disorder": 3.42, "polymyalgia rheumatica": 4.79, "post herpetic neuralgia": 40.91, "product administered at inappropriate site": 4.54, "product administered to patient of inappropriate age": 16.71, "product supply issue": 7.51, "pruritus": 2.22, "pustule": 5.77, "radiculopathy": 3.19, "rash": 2.79, "rash erythematous": 2.01, "rash papular": 2.55, "rash pruritic": 2.47, "rash pustular": 5.2, "rash vesicular": 33.94, "scab": 5.24, "scar": 4.44, "skin lesion": 4.21, "skin warm": 6.61, "social problem": 2.71, "swelling": 2.75, "tenderness": 2.2, "trigeminal neuralgia": 4.17, "vaccination failure": 6.68, "vaccination site erythema": 2.7, "vaccination site induration": 2.04, "vaccination site inflammation": 4.8, "vaccination site joint swelling": 3.17, "vaccination site rash": 2.09, "vaccination site reaction": 2.09, "vaccination site swelling": 2.2, "vaccination site warmth": 3.16, "varicella zoster virus infection": 11.26, "walking aid user": 2.47}
|
||||
{"ejaculation disorder": 1308.99, "ejaculation failure": 590.54, "loss of consciousness": 8.96, "orthostatic hypotension": 46.34, "prostate cancer": 83.32, "retrograde ejaculation": 1278.25, "syncope": 5.36}
|
||||
@@ -1 +1 @@
|
||||
{"abnormal behaviour": 3.84, "abnormal dreams": 5.07, "aggression": 5.48, "agitation": 4.12, "behaviour disorder": 16.37, "bulimia nervosa": 157.29, "cardiac failure": 2.5, "circulatory collapse": 2.37, "compulsive shopping": 690.24, "condition aggravated": 2.14, "confusional state": 4.3, "constipation": 2.63, "delirium": 5.55, "delusion": 6.56, "dependence": 21.75, "depression": 2.1, "diplopia": 3.64, "dyskinesia": 11.49, "eating disorder": 8.95, "fall": 2.32, "gambling": 234.34, "gambling disorder": 890.15, "hallucination": 18.36, "hallucination, auditory": 8.62, "hallucination, visual": 23.07, "hyperkinesia": 43.9, "hypersexuality": 336.87, "impulse-control disorder": 488.63, "insomnia": 3.48, "libido increased": 55.99, "mania": 6.05, "medication error": 3.63, "mental disorder": 3.99, "muscle rigidity": 5.06, "nightmare": 3.03, "obsessive-compulsive disorder": 21.59, "oedema peripheral": 6.53, "orthostatic hypotension": 5.8, "overdose": 2.61, "paranoia": 6.37, "parkinson's disease": 14.3, "parkinsonism": 11.22, "personality change": 14.34, "product residue present": 10.32, "psychomotor hyperactivity": 17.5, "psychotic disorder": 5.57, "restless legs syndrome": 20.6, "restlessness": 3.5, "rhabdomyolysis": 2.26, "road traffic accident": 6.41, "sleep attacks": 117.43, "sleep disorder": 5.58, "somnolence": 4.46, "stereotypy": 113.41, "sudden onset of sleep": 109.44, "suicide attempt": 4.85, "therapeutic product effect decreased": 2.27, "tremor": 2.29, "weight increased": 3.1, "withdrawal syndrome": 4.26}
|
||||
{"dizziness": 2.43, "ejaculation failure": 1537.73, "erectile dysfunction": 58.37, "fall": 3.3, "hypotension": 3.72, "nasal congestion": 29.48, "orthostatic hypotension": 44.44, "retrograde ejaculation": 3048.04, "syncope": 2.43}
|
||||
@@ -1 +1 @@
|
||||
{"blood glucose increased": 8.11, "diabetes mellitus": 35.47, "diarrhoea": 2.79, "electrocardiogram qt prolonged": 9.68, "glycosylated haemoglobin increased": 33.94, "hyperglycaemia": 59.28, "product use in unapproved indication": 3.17, "weight decreased": 3.2}
|
||||
{"blepharitis": 53.85, "blindness": 3.46, "blindness unilateral": 8.21, "blood pressure decreased": 9.87, "cataract": 3.4, "conjunctival hyperaemia": 70.15, "conjunctivitis": 35.7, "conjunctivitis allergic": 94.83, "depression": 2.14, "drug hypersensitivity": 2.09, "drug intolerance": 6.3, "dry eye": 18.48, "dry mouth": 22.85, "dry throat": 14.83, "dysgeusia": 2.96, "eczema": 2.8, "eczema eyelids": 414.57, "erythema of eyelid": 128.48, "eye allergy": 455.97, "eye discharge": 66.88, "eye disorder": 5.86, "eye inflammation": 11.99, "eye irritation": 98.42, "eye pain": 15.91, "eye pruritus": 62.2, "eye swelling": 7.79, "eyelid irritation": 96.39, "eyelid oedema": 14.09, "foreign body sensation in eyes": 110.6, "glaucoma": 20.87, "hypersensitivity": 3.3, "hypotension": 3.81, "incorrect dose administered": 3.63, "intraocular pressure increased": 52.37, "keratitis": 67.82, "lacrimation increased": 27.99, "liquid product physical issue": 22.77, "nightmare": 4.53, "ocular discomfort": 13.44, "ocular hyperaemia": 134.94, "photophobia": 6.04, "product packaging quantity issue": 99.17, "product physical consistency issue": 200.13, "product quality issue": 21.01, "sleep disorder": 2.15, "somnolence": 3.32, "swelling of eyelid": 31.36, "uveitis": 29.23, "vision blurred": 8.52, "visual acuity reduced": 4.07, "visual impairment": 5.22, "wrong technique in product usage process": 4.92}
|
||||
@@ -1 +1 @@
|
||||
{"accidental overdose": 42.45, "anaemia": 10.7, "neutropenia": 22.59, "pancytopenia": 61.83, "thrombocytopenia": 22.21}
|
||||
{"blood bilirubin increased": 16.81, "drug ineffective": 8.4, "drug interaction": 11.56, "hepatitis c": 263.22, "hyperbilirubinaemia": 46.22, "off label use": 10.66, "photosensitivity reaction": 30.16, "product use issue": 21.2, "treatment failure": 25.08}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"anogenital warts": 338.53, "cervical dysplasia": 223.59, "loss of consciousness": 3.05, "muscular weakness": 3.3, "papilloma viral infection": 303.78, "syncope": 5.3, "vertigo": 5.7}
|
||||
{"anaphylactic reaction": 3.47, "anaphylactic shock": 12.09, "anuria": 40.01, "blood creatinine increased": 21.83, "blood pressure decreased": 4.09, "bronchospasm": 15.2, "cardiac arrest": 3.64, "complications of transplanted kidney": 455.11, "cytomegalovirus infection": 30.96, "haemoglobin decreased": 4.61, "hypotension": 7.72, "hypoxia": 5.33, "kidney transplant rejection": 690.32, "liver transplant rejection": 175.14, "nephropathy toxic": 16.74, "oliguria": 35.49, "oxygen saturation decreased": 3.17, "pulmonary oedema": 12.65, "renal impairment": 5.01, "renal tubular necrosis": 101.34, "renal vein thrombosis": 200.17, "sepsis": 3.84, "shock": 18.85, "thrombotic microangiopathy": 16.08, "transplant rejection": 303.75, "tubulointerstitial nephritis": 17.74, "urinary tract infection": 2.14, "urine output decreased": 56.1}
|
||||
@@ -1 +1 @@
|
||||
{"ejaculation disorder": 592.9, "ejaculation failure": 289.37, "loss of consciousness": 7.74, "orthostatic hypotension": 29.99, "prostate cancer": 6.64, "retrograde ejaculation": 956.1, "syncope": 5.62}
|
||||
{"acute kidney injury": 5.4, "angioedema": 16.42, "drug interaction": 32.46, "off label use": 3.86, "product use in unapproved indication": 14.53}
|
||||
@@ -1 +1 @@
|
||||
{"dizziness": 2.67, "ejaculation failure": 726.53, "erectile dysfunction": 33.21, "fall": 2.87, "hypotension": 2.61, "nasal congestion": 30.07, "orthostatic hypotension": 28.76, "retrograde ejaculation": 2169.05, "syncope": 2.55}
|
||||
{"anaemia": 3.07, "death": 2.01, "electrocardiogram qt prolonged": 260.94, "intentional product use issue": 15.06, "off label use": 5.07}
|
||||
@@ -1 +1 @@
|
||||
{"blepharitis": 53.78, "blindness": 3.45, "blindness unilateral": 8.9, "blood pressure decreased": 7.27, "cataract": 3.03, "conjunctival hyperaemia": 43.36, "conjunctivitis": 30.19, "conjunctivitis allergic": 70.4, "drug intolerance": 6.15, "dry eye": 17.0, "dry mouth": 16.8, "dry throat": 12.46, "dysgeusia": 2.8, "eczema": 2.67, "eczema eyelids": 367.98, "erythema of eyelid": 98.56, "eye allergy": 399.23, "eye discharge": 57.16, "eye disorder": 5.33, "eye inflammation": 13.66, "eye irritation": 76.27, "eye pain": 17.86, "eye pruritus": 53.78, "eye swelling": 6.53, "eyelid irritation": 89.48, "eyelid oedema": 9.02, "foreign body sensation in eyes": 95.46, "glaucoma": 15.69, "hypersensitivity": 2.47, "hypotension": 2.67, "intraocular pressure increased": 44.24, "keratitis": 56.39, "lacrimation increased": 25.05, "liquid product physical issue": 26.28, "nightmare": 3.18, "ocular discomfort": 14.61, "ocular hyperaemia": 114.3, "photophobia": 6.78, "product packaging quantity issue": 61.77, "product physical consistency issue": 53.21, "product quality issue": 11.12, "sleep disorder": 2.04, "somnolence": 2.75, "swelling of eyelid": 25.13, "uveitis": 35.03, "vision blurred": 8.44, "visual acuity reduced": 4.35, "visual impairment": 5.15, "wrong technique in product usage process": 3.52}
|
||||
{"angioedema": 9.47, "completed suicide": 46.55, "diabetes mellitus inadequate control": 26.9, "drug interaction": 7.08, "hypoglycaemia": 15.24, "lactic acidosis": 75.7, "pemphigoid": 50.2, "toxicity to various agents": 14.57}
|
||||
@@ -1 +1 @@
|
||||
{"alanine aminotransferase increased": 2.79, "anaemia": 2.31, "arthritis": 3.88, "dehydration": 2.33, "diarrhoea": 2.95, "disease progression": 29.18, "dysphonia": 8.37, "febrile neutropenia": 10.62, "general physical health deterioration": 4.41, "hepatitis": 5.02, "hypertension": 5.64, "hyperthyroidism": 13.94, "hypothyroidism": 29.37, "infusion related reaction": 30.23, "mucosal inflammation": 11.84, "myocarditis": 5.96, "myositis": 20.13, "neoplasm progression": 27.46, "off label use": 4.03, "pneumonitis": 8.31, "sepsis": 2.41, "thrombocytopenia": 2.53}
|
||||
{"breast cancer": 9.43, "depression": 2.8, "fall": 3.2, "gait disturbance": 4.82, "memory impairment": 2.99, "multiple sclerosis": 31.15, "multiple sclerosis relapse": 33.35, "muscle spasticity": 37.85, "urinary tract infection": 3.09}
|
||||
@@ -1 +1 @@
|
||||
{"blood bilirubin increased": 15.17, "drug ineffective": 8.0, "drug interaction": 7.72, "hepatitis c": 342.71, "hyperbilirubinaemia": 42.05, "off label use": 10.7, "photosensitivity reaction": 26.04, "product use issue": 19.18, "treatment failure": 29.2}
|
||||
{"anaemia": 6.64, "off label use": 5.34, "thrombocytopenia": 13.88}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"anaphylactic reaction": 2.49, "anaphylactic shock": 4.6, "anuria": 25.01, "blood creatinine increased": 19.68, "blood pressure decreased": 3.02, "bronchospasm": 8.26, "cardiac arrest": 2.55, "complications of transplanted kidney": 515.99, "cytomegalovirus infection": 35.79, "haemoglobin decreased": 4.59, "hypotension": 5.4, "hypoxia": 4.55, "kidney transplant rejection": 790.82, "liver transplant rejection": 206.98, "nephropathy toxic": 13.48, "oliguria": 21.67, "oxygen saturation decreased": 2.79, "pulmonary oedema": 11.15, "renal impairment": 4.7, "renal tubular necrosis": 82.19, "renal vein thrombosis": 231.87, "sepsis": 3.81, "shock": 10.74, "thrombotic microangiopathy": 19.0, "transplant rejection": 338.43, "tubulointerstitial nephritis": 12.44, "urinary tract infection": 2.23, "urine output decreased": 41.94}
|
||||
{"abortion spontaneous": 3.15, "acne": 3.29, "arthritis": 2.69, "arthropathy": 3.26, "breast cancer": 4.73, "breast cancer female": 38.34, "c-reactive protein increased": 3.09, "crohn's disease": 4.78, "dermatitis exfoliative generalised": 14.02, "device issue": 14.82, "drug hypersensitivity": 2.14, "eczema": 5.22, "erythema": 2.04, "fungal infection": 4.96, "hepatic cirrhosis": 6.62, "hospitalisation": 2.13, "infection": 2.43, "injection site haemorrhage": 7.19, "intentional product misuse": 2.7, "intestinal obstruction": 5.4, "lung neoplasm malignant": 4.81, "lymphoma": 9.7, "maternal exposure during pregnancy": 3.69, "prostate cancer": 6.28, "pruritus": 2.16, "psoriasis": 47.63, "psoriatic arthropathy": 11.28, "skin disorder": 2.74, "skin exfoliation": 4.88, "skin lesion": 4.05, "skin plaque": 28.16, "stress": 3.67, "surgery": 4.49, "therapeutic product effect decreased": 4.72, "therapeutic product effect incomplete": 4.56, "therapeutic response shortened": 49.24, "tuberculosis": 8.41, "unevaluable event": 15.5}
|
||||
@@ -1 +1 @@
|
||||
{"acute kidney injury": 3.85, "angioedema": 9.02, "drug interaction": 21.68, "off label use": 3.87, "product use in unapproved indication": 10.29}
|
||||
{"aggression": 132.53, "agitation": 53.7, "irritability": 32.26, "middle insomnia": 126.23, "product administered to patient of inappropriate age": 126.51, "somnolence": 4.01}
|
||||
@@ -1 +1 @@
|
||||
{"anaemia": 3.16, "electrocardiogram qt prolonged": 167.77, "intentional product use issue": 13.62, "off label use": 5.09}
|
||||
{"drug abuse": 36.87, "drug interaction": 16.8, "overdose": 26.66, "toxicity to various agents": 35.14}
|
||||
@@ -1 +1 @@
|
||||
{"angioedema": 5.2, "completed suicide": 19.51, "diabetes mellitus inadequate control": 30.29, "drug interaction": 4.73, "hypoglycaemia": 14.88, "lactic acidosis": 30.01, "pemphigoid": 49.19, "toxicity to various agents": 6.66}
|
||||
{"bradycardia": 7.84, "death": 2.37, "drug ineffective": 7.62, "drug interaction": 5.82, "genotype drug resistance test positive": 119.58, "hepatitis c": 92.68, "hepatocellular carcinoma": 25.72, "intentional dose omission": 109.36, "product dose omission issue": 7.69, "treatment failure": 50.2}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"abdominal discomfort": 13.75, "abdominal pain": 4.21, "abdominal pain upper": 10.16, "alanine aminotransferase increased": 3.13, "aspartate aminotransferase increased": 2.36, "burning sensation": 4.01, "diarrhoea": 6.65, "drug intolerance": 5.01, "eosinophil count increased": 30.08, "eosinophilia": 35.96, "erythema": 3.87, "feeling hot": 2.62, "flatulence": 4.94, "flushing": 56.67, "gastrointestinal disorder": 16.7, "gastrointestinal pain": 24.15, "hot flush": 11.34, "leukopenia": 6.09, "lymphocyte count decreased": 109.03, "lymphopenia": 278.26, "proteinuria": 9.45, "pruritus": 2.69, "psoriasis": 29.48, "skin burning sensation": 12.56, "therapeutic response unexpected": 17.95}
|
||||
{"injection site pain": 8.46, "nausea": 3.07}
|
||||
@@ -1 +1 @@
|
||||
{"abortion spontaneous": 2.83, "acne": 2.91, "arthritis": 2.87, "arthropathy": 3.47, "breast cancer female": 3.88, "c-reactive protein increased": 3.1, "crohn's disease": 5.97, "dermatitis exfoliative generalised": 8.61, "device issue": 13.99, "eczema": 4.97, "fungal infection": 5.04, "hepatic cirrhosis": 6.75, "hospitalisation": 2.05, "infection": 2.58, "injection site haemorrhage": 7.31, "intestinal obstruction": 4.76, "lymphoma": 7.89, "maternal exposure during pregcy": 3.52, "psoriasis": 58.36, "psoriatic arthropathy": 14.94, "skin disorder": 3.07, "skin exfoliation": 3.86, "skin lesion": 3.81, "skin plaque": 23.29, "stress": 3.34, "surgery": 4.09, "therapeutic product effect decreased": 4.36, "therapeutic product effect incomplete": 4.51, "therapeutic response shortened": 56.02, "tuberculosis": 9.29, "unevaluable event": 13.77, "urinary tract infection": 2.06}
|
||||
{"apnoea": 19.06, "aspartate aminotransferase increased": 2.78, "blood alkaline phosphatase increased": 5.29, "brain neoplasm": 45.4, "condition aggravated": 2.97, "contusion": 2.35, "craniopharyngioma": 2184.24, "dehydration": 2.06, "diabetes mellitus": 8.06, "disease recurrence": 9.42, "drug abuse": 8.95, "drug intolerance": 2.03, "eating disorder": 7.12, "epiphysiolysis": 2529.5, "fluid retention": 3.99, "focal nodular hyperplasia": 207.24, "gastrointestinal infection": 28.55, "glucose tolerance impaired": 109.45, "glycosylated haemoglobin increased": 4.62, "head injury": 5.74, "hypoglycaemia": 3.39, "idiopathic intracranial hypertension": 430.26, "incorrect dose administered": 2.11, "increased appetite": 15.08, "injection site atrophy": 79.25, "injection site bruising": 12.97, "injection site haemorrhage": 11.68, "insulin-like growth factor increased": 445.6, "intentional product misuse": 3.3, "intracranial pressure increased": 69.16, "lower limb fracture": 15.32, "meningioma": 115.26, "neoplasm recurrence": 96.01, "obstructive sleep apnoea syndrome": 141.91, "off label use": 3.59, "pancreatitis acute": 7.21, "papilloedema": 32.94, "pituitary tumour benign": 88.72, "product dose omission issue": 3.23, "product prescribing error": 19.86, "product use in unapproved indication": 2.14, "protein-losing gastroenteropathy": 290.66, "scoliosis": 161.02, "sleep apnoea syndrome": 66.78, "snoring": 131.21, "stress": 3.54, "sudden death": 21.49, "sulphaemoglobinaemia": 3569.79, "therapeutic response unexpected": 4.77, "tonsillar disorder": 263.45, "type 2 diabetes mellitus": 12.08, "viral infection": 4.88, "weight increased": 2.05}
|
||||
@@ -1 +1 @@
|
||||
{"aggression": 81.16, "agitation": 35.1, "irritability": 28.02, "middle insomnia": 121.03, "product administered to patient of inappropriate age": 103.26, "somnolence": 3.31}
|
||||
{"abdominal distension": 2.86, "acromegaly": 1048.42, "alanine aminotransferase increased": 2.02, "amnesia": 2.69, "arterial occlusive disease": 12.09, "arthritis": 2.55, "arthropathy": 3.3, "blood cholesterol abnormal": 29.3, "blood cholesterol increased": 5.17, "blood glucose abnormal": 2.81, "blood growth hormone increased": 2275.28, "bradycardia": 2.2, "brain neoplasm": 29.93, "cholelithiasis": 10.67, "constipation": 2.03, "diabetes mellitus": 5.09, "gait disturbance": 2.25, "glycosylated haemoglobin increased": 5.75, "heart rate decreased": 4.86, "hepatic enzyme increased": 3.38, "hip fracture": 3.31, "incorrect dose administered": 3.35, "incorrect route of product administration": 5.74, "injection site bruising": 38.75, "injection site haematoma": 4.52, "injection site haemorrhage": 10.45, "injection site induration": 2.86, "injection site mass": 7.27, "injection site oedema": 5.14, "insulin-like growth factor abnormal": 1907.27, "insulin-like growth factor decreased": 1322.59, "insulin-like growth factor increased": 2493.68, "intentional dose omission": 9.05, "intentional product misuse": 8.87, "limb injury": 7.72, "lipodystrophy acquired": 29.63, "lipohypertrophy": 110.79, "liver disorder": 2.22, "needle issue": 35.58, "neoplasm": 40.03, "neoplasm malignant": 4.11, "neoplasm progression": 5.41, "off label use": 4.48, "osteoarthritis": 2.8, "pituitary tumour": 434.39, "pituitary tumour benign": 165.1, "pituitary tumour recurrent": 728.27, "polyp": 29.42, "poor quality product administered": 41.23, "product complaint": 20.48, "product dose omission in error": 12.19, "product dose omission issue": 9.12, "product preparation issue": 11.05, "product storage error": 5.28, "product use issue": 14.22, "road traffic accident": 3.23, "syringe issue": 20.03, "tendonitis": 4.61, "therapeutic product effect incomplete": 4.52, "therapeutic response unexpected": 3.18, "vital functions abnormal": 110.21, "weight increased": 3.15, "wound infection": 21.04, "wrong technique in device usage process": 17.23, "wrong technique in product usage process": 3.95}
|
||||
@@ -1 +1 @@
|
||||
{"depression": 2.26, "fall": 2.79, "gait disturbance": 4.59, "influenza like illness": 2.57, "memory impairment": 2.73, "multiple sclerosis": 38.78, "multiple sclerosis relapse": 45.75, "muscle spasticity": 36.87, "urinary tract infection": 3.22}
|
||||
{"cytokine release syndrome": 461.43, "cytokine storm": 280.68, "cytopenia": 31.67, "disease progression": 7.54, "encephalopathy": 37.72, "febrile neutropenia": 5.47, "hypogammaglobulinaemia": 108.61, "hypotension": 2.09, "immune effector cell-associated neurotoxicity syndrome": 597.4, "neurotoxicity": 129.31, "neutropenia": 8.04, "pancytopenia": 13.63, "thrombocytopenia": 5.92}
|
||||
@@ -1 +1 @@
|
||||
{"drug abuse": 11.51, "drug interaction": 11.22, "overdose": 11.78, "toxicity to various agents": 16.07}
|
||||
{"hallucination": 12.35, "intentional overdose": 176.21, "overdose": 25.35, "somnolence": 6.5, "suicide attempt": 26.71, "tachycardia": 4.35}
|
||||
@@ -1 +1 @@
|
||||
{"anaemia": 2.97, "bradycardia": 9.72, "drug ineffective": 7.68, "drug interaction": 5.21, "hepatitis c": 199.66, "hepatocellular carcinoma": 79.08, "treatment failure": 106.12}
|
||||
{"dysgeusia": 40.84, "muscle spasms": 33.93}
|
||||
@@ -1 +1 @@
|
||||
{"death": 3.71, "drug ineffective": 5.98, "hepatitis c": 38.7, "intentional dose omission": 187.49, "product dose omission issue": 12.51, "seizure": 2.47}
|
||||
{"anaphylactic reaction": 27.91, "anaphylactic shock": 113.92, "anaphylactoid reaction": 76.61, "blood pressure decreased": 23.02, "blood pressure immeasurable": 289.06, "bradycardia": 23.03, "bronchospasm": 13.46, "cardiac arrest": 13.73, "cardio-respiratory arrest": 16.03, "chest discomfort": 2.58, "circulatory collapse": 5.65, "cold sweat": 6.82, "contrast media reaction": 887.79, "cyanosis": 22.41, "depressed level of consciousness": 2.82, "dyspnoea": 3.27, "electrocardiogram st segment elevation": 28.4, "erythema": 8.07, "feeling hot": 6.06, "flushing": 18.4, "heart rate decreased": 10.6, "hyperhidrosis": 5.45, "hypersensitivity": 12.06, "hypotension": 20.27, "loss of consciousness": 6.41, "ocular hyperaemia": 4.66, "off label use": 2.15, "oxygen saturation decreased": 10.56, "pallor": 4.77, "paraesthesia oral": 3.56, "presyncope": 6.13, "pruritus": 2.19, "pulse absent": 45.84, "rash": 2.35, "rash erythematous": 2.19, "respiratory arrest": 9.46, "respiratory distress": 5.9, "resuscitation": 52.76, "shock": 7.55, "tachycardia": 2.78, "throat irritation": 3.08, "throat tightness": 6.41, "unresponsive to stimuli": 5.45, "urticaria": 3.69, "ventricular fibrillation": 17.97}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"injection site pain": 11.67, "nausea": 3.46}
|
||||
{"alanine aminotransferase increased": 13.5, "anaemia": 2.08, "aspartate aminotransferase increased": 12.98, "blood bilirubin increased": 11.33, "diarrhoea": 5.66, "disease progression": 9.92, "drug-induced liver injury": 18.64, "hepatic enzyme increased": 8.66, "hepatic function abnormal": 14.66, "hepatotoxicity": 53.53, "liver disorder": 9.49, "liver function test increased": 18.65, "lung adenocarcinoma": 115.9, "lung neoplasm malignant": 18.42, "non-small cell lung cancer": 630.84, "non-small cell lung cancer metastatic": 1967.99, "off label use": 2.26, "pneumonia": 2.18, "therapy partial responder": 68.37}
|
||||
@@ -1 +1 @@
|
||||
{"apnoea": 13.4, "aspartate aminotransferase increased": 2.31, "blood alkaline phosphatase increased": 3.99, "brain neoplasm": 35.71, "condition aggravated": 2.83, "contusion": 2.58, "craniopharyngioma": 589.33, "diabetes mellitus": 7.61, "disease recurrence": 11.16, "drug abuse": 2.79, "eating disorder": 6.36, "epiphysiolysis": 778.18, "fluid retention": 3.76, "focal nodular hyperplasia": 163.38, "gastrointestinal infection": 28.39, "glucose tolerance impaired": 90.41, "glycosylated haemoglobin increased": 5.24, "head injury": 5.09, "hypoglycaemia": 3.31, "hypothyroidism": 2.01, "idiopathic intracranial hypertension": 250.89, "increased appetite": 12.82, "injection site atrophy": 95.03, "injection site bruising": 12.17, "injection site haemorrhage": 11.88, "insulin-like growth factor increased": 268.58, "intracranial pressure increased": 53.46, "lower limb fracture": 14.49, "meningioma": 37.33, "neoplasm recurrence": 102.1, "obstructive sleep apnoea syndrome": 138.43, "off label use": 3.64, "osteonecrosis": 2.54, "pancreatitis acute": 6.63, "papilloedema": 27.76, "pituitary tumour benign": 62.16, "product dose omission issue": 2.87, "product prescribing error": 12.07, "protein-losing gastroenteropathy": 221.79, "scoliosis": 116.6, "sleep apnoea syndrome": 58.68, "snoring": 102.17, "stress": 3.23, "sudden death": 21.85, "sulphaemoglobinaemia": 1448.89, "therapeutic response unexpected": 3.22, "tonsillar disorder": 216.49, "type 2 diabetes mellitus": 11.12, "viral infection": 4.93}
|
||||
{"bradycardia": 8.35, "dyspnoea": 2.4, "hypotension": 6.11, "oxygen saturation decreased": 16.85}
|
||||
@@ -1 +1 @@
|
||||
{"abdominal distension": 2.53, "acromegaly": 353.0, "amnesia": 2.19, "arterial occlusive disease": 10.65, "arthritis": 2.72, "arthropathy": 3.51, "blood cholesterol abnormal": 26.38, "blood cholesterol increased": 4.55, "blood glucose abnormal": 3.29, "blood growth hormone increased": 777.64, "brain neoplasm": 23.52, "cholelithiasis": 9.8, "diabetes mellitus": 4.81, "gait disturbance": 2.15, "glycosylated haemoglobin increased": 6.52, "heart rate decreased": 3.91, "hepatic enzyme increased": 2.85, "hip fracture": 2.91, "incorrect route of product administration": 4.06, "injection site bruising": 36.18, "injection site haematoma": 5.97, "injection site haemorrhage": 10.62, "injection site induration": 3.66, "injection site mass": 8.67, "injection site oedema": 5.47, "injection site reaction": 2.04, "insulin-like growth factor abnormal": 1462.37, "insulin-like growth factor decreased": 516.62, "insulin-like growth factor increased": 966.53, "intentional dose omission": 8.5, "intentional product misuse": 4.59, "limb injury": 7.39, "lipodystrophy acquired": 39.93, "lipohypertrophy": 129.48, "needle issue": 26.15, "neoplasm": 37.79, "neoplasm progression": 7.09, "off label use": 4.5, "osteoarthritis": 2.92, "pituitary tumour": 244.26, "pituitary tumour benign": 112.46, "pituitary tumour recurrent": 337.98, "polyp": 21.94, "poor quality product administered": 23.25, "product complaint": 7.5, "product dose omission in error": 10.26, "product dose omission issue": 8.09, "product preparation issue": 9.07, "product storage error": 5.23, "product use issue": 12.84, "road traffic accident": 2.5, "syringe issue": 18.48, "tendonitis": 2.8, "therapeutic product effect incomplete": 4.47, "therapeutic response unexpected": 2.15, "vital functions abnormal": 98.47, "weight increased": 2.92, "wound infection": 21.53, "wrong technique in device usage process": 11.27, "wrong technique in product usage process": 2.82}
|
||||
{"anaemia": 8.31, "ascites": 9.58, "blood bilirubin increased": 7.58, "bradycardia": 2.57, "cerebral haemorrhage": 2.2, "cerebral infarction": 2.65, "death": 2.02, "depression": 2.58, "drug ineffective": 12.03, "haematemesis": 2.93, "haemoglobin decreased": 7.59, "haemolytic anaemia": 10.29, "hepatic cancer": 31.79, "hepatic cancer recurrent": 555.13, "hepatic cirrhosis": 26.13, "hepatic encephalopathy": 32.41, "hepatic failure": 6.56, "hepatitis": 4.14, "hepatitis b reactivation": 18.56, "hepatitis c": 159.51, "hepatitis c rna positive": 200.65, "hepatocellular carcinoma": 56.46, "hyperbilirubinaemia": 19.95, "jaundice": 9.43, "loss of consciousness": 2.02, "multiple organ dysfunction syndrome": 3.17, "neoplasm malignant": 3.19, "oedema peripheral": 2.01, "oesophageal varices haemorrhage": 35.87, "pancreatitis acute": 2.61, "renal impairment": 4.29, "septic shock": 3.07, "treatment failure": 26.28, "treatment noncompliance": 3.97, "viral load increased": 25.19, "virologic failure": 23.31}
|
||||
@@ -1 +1 @@
|
||||
{"hallucination": 8.51, "intentional overdose": 63.23, "overdose": 11.21, "somnolence": 5.37, "suicide attempt": 13.92, "tachycardia": 4.3}
|
||||
{"drug ineffective": 6.33}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"anaphylactic reaction": 19.98, "anaphylactic shock": 42.45, "anaphylactoid reaction": 33.04, "blood pressure decreased": 16.93, "blood pressure immeasurable": 118.39, "bradycardia": 12.83, "bronchospasm": 7.31, "cardiac arrest": 9.62, "cardio-respiratory arrest": 10.26, "chest discomfort": 2.72, "circulatory collapse": 4.01, "cold sweat": 7.26, "contrast media reaction": 88.42, "cyanosis": 16.08, "depressed level of consciousness": 2.0, "dyspnoea": 3.14, "electrocardiogram st segment elevation": 21.58, "erythema": 6.4, "feeling hot": 7.09, "flushing": 14.24, "heart rate decreased": 8.52, "hyperhidrosis": 5.51, "hypersensitivity": 9.03, "hypotension": 14.15, "loss of consciousness": 5.53, "ocular hyperaemia": 3.99, "off label use": 2.15, "oxygen saturation decreased": 9.26, "pallor": 4.54, "paraesthesia": 2.0, "paraesthesia oral": 3.5, "presyncope": 6.63, "pulse absent": 24.98, "rash": 2.1, "respiratory arrest": 5.3, "respiratory distress": 4.94, "resuscitation": 46.11, "shock": 4.31, "tachycardia": 2.75, "throat irritation": 2.18, "throat tightness": 5.34, "unresponsive to stimuli": 4.15, "urticaria": 2.76, "ventricular fibrillation": 11.05}
|
||||
{"acute respiratory failure": 15.82, "apnoea": 9.47, "aspiration": 46.93, "atelectasis": 38.41, "back pain": 3.26, "brain injury": 10.13, "bronchial secretion retention": 99.02, "bronchiolitis": 15.18, "bronchitis": 3.94, "cardiac arrest": 6.72, "cardio-respiratory arrest": 13.01, "cerebrospinal fluid leakage": 195.96, "choking": 7.99, "chronic respiratory failure": 70.29, "csf pressure increased": 762.42, "csf protein increased": 105.8, "death": 2.66, "dehydration": 2.76, "device dislocation": 23.1, "dysphagia": 3.94, "enterovirus infection": 139.86, "epilepsy": 2.0, "fall": 2.16, "femur fracture": 18.15, "gait inability": 6.8, "gastrointestinal infection": 16.59, "hip fracture": 4.58, "hydrocephalus": 42.1, "hypokalaemia": 2.46, "hypoxia": 2.88, "increased bronchial secretion": 36.61, "infection": 3.41, "intracranial pressure increased": 27.34, "joint dislocation": 27.98, "lower limb fracture": 7.31, "malnutrition": 16.91, "meningitis": 8.84, "meningitis aseptic": 14.12, "mobility decreased": 2.76, "motor dysfunction": 17.14, "muscle contracture": 21.47, "muscular weakness": 2.13, "nephrolithiasis": 6.25, "neurological examination abnormal": 181.51, "neurological procedural complication": 1546.46, "oxygen saturation decreased": 5.33, "parainfluenzae virus infection": 51.79, "pneumonia": 8.32, "pneumonia aspiration": 8.74, "pneumonia viral": 21.24, "pneumothorax": 11.7, "post lumbar puncture syndrome": 6259.55, "post procedural complication": 54.71, "post procedural infection": 21.84, "prescribed underdose": 5.41, "procedural complication": 76.37, "procedural nausea": 217.48, "procedural pain": 275.91, "procedural vomiting": 288.72, "proteinuria": 6.42, "respiratory arrest": 14.33, "respiratory disorder": 22.28, "respiratory distress": 7.55, "respiratory failure": 10.43, "respiratory syncytial virus infection": 29.95, "respiratory tract infection": 29.38, "respiratory tract infection viral": 40.3, "rhinovirus infection": 198.16, "sars-cov-2 test positive": 2.58, "scoliosis": 625.18, "sepsis": 2.95, "spinal deformity": 77.5, "spinal muscular atrophy": 2844.61, "therapeutic product effect decreased": 3.92, "traumatic lumbar puncture": 1230.18, "upper respiratory tract infection": 5.49, "urinary retention": 2.03, "viral infection": 11.54}
|
||||
@@ -1 +1 @@
|
||||
{"cytokine release syndrome": 624.42, "cytokine storm": 327.54, "cytopenia": 35.47, "disease progression": 8.44, "encephalopathy": 25.42, "febrile neutropenia": 5.99, "hypogammaglobulinaemia": 132.23, "immune effector cell-associated neurotoxicity syndrome": 842.79, "neurotoxicity": 115.14, "neutropenia": 8.23, "pancytopenia": 12.74, "thrombocytopenia": 5.57}
|
||||
{"acute kidney injury": 2.97, "adrenal insufficiency": 9.18, "alanine aminotransferase increased": 5.42, "aspartate aminotransferase increased": 4.73, "blood bilirubin increased": 2.66, "blood pressure increased": 2.98, "blood thyroid stimulating hormone increased": 13.81, "colitis": 2.57, "decreased appetite": 2.77, "dehydration": 2.24, "diarrhoea": 4.73, "disease progression": 5.65, "drug-induced liver injury": 6.94, "dysphonia": 15.69, "general physical health deterioration": 3.43, "hepatic function abnormal": 6.44, "hepatitis": 18.99, "hepatotoxicity": 13.6, "hyperkalaemia": 4.01, "hypertension": 10.47, "hyperthyroidism": 7.56, "hypertransaminasaemia": 10.46, "hypothyroidism": 29.82, "immune-mediated hepatic disorder": 45.03, "immune-mediated hypothyroidism": 35.31, "immune-mediated myocarditis": 25.21, "liver disorder": 3.2, "liver function test increased": 3.53, "malignant neoplasm progression": 11.27, "metastatic renal cell carcinoma": 19.56, "mucosal inflammation": 9.5, "neoplasm progression": 24.16, "off label use": 2.5, "osteonecrosis of jaw": 10.06, "palmar-plantar erythrodysaesthesia syndrome": 22.89, "pancreatitis acute": 2.66, "pneumonitis": 2.93, "polycythaemia": 50.11, "posterior reversible encephalopathy syndrome": 22.1, "product use in unapproved indication": 3.34, "proteinuria": 10.4, "stomatitis": 5.57, "therapy partial responder": 24.95, "thyroiditis": 14.65, "transaminases increased": 6.63, "tubulointerstitial nephritis": 8.91, "weight decreased": 3.16}
|
||||
@@ -1 +1 @@
|
||||
{"alopecia": 2.33, "alpha 1 foetoprotein increased": 150.74, "anaemia": 2.23, "ascites": 6.88, "blister": 4.3, "diarrhoea": 3.25, "disease progression": 4.13, "drug ineffective for unapproved indication": 8.0, "drug intolerance": 2.37, "drug-induced liver injury": 2.74, "erythema multiforme": 6.54, "haematotoxicity": 15.46, "hepatic encephalopathy": 14.76, "hepatic failure": 8.07, "hepatocellular carcinoma": 72.34, "hepatotoxicity": 6.28, "hyperkeratosis": 26.22, "hypertension": 3.53, "hypocalcaemia": 12.63, "metastases to bone": 7.58, "metastases to lung": 32.16, "metastatic renal cell carcinoma": 27.27, "mucosal inflammation": 11.39, "off label use": 6.09, "osteonecrosis of jaw": 14.21, "palmar-plantar erythrodysaesthesia syndrome": 103.78, "product use in unapproved indication": 9.24, "product use issue": 2.69, "rash maculo-papular": 2.75, "renal cell carcinoma": 12.98, "skin exfoliation": 3.25, "skin reaction": 4.31, "skin toxicity": 60.05, "skin ulcer": 6.08, "squamous cell carcinoma of skin": 29.66, "stevens-johnson syndrome": 3.73, "stomatitis": 2.07, "thrombocytopenia": 3.94, "tumour lysis syndrome": 15.07, "weight decreased": 2.45}
|
||||
{"acute kidney injury": 15.65, "asthenia": 3.42, "atrial fibrillation": 2.27, "blood creatinine increased": 4.29, "blood potassium increased": 17.14, "bradycardia": 6.81, "dehydration": 4.54, "drug interaction": 4.52, "drug reaction with eosinophilia and systemic symptoms": 26.72, "gynaecomastia": 76.22, "hyperkalaemia": 148.35, "hypokalaemia": 11.68, "hyponatraemia": 25.69, "hypotension": 7.52, "metabolic acidosis": 12.02, "oedema peripheral": 3.38, "orthostatic hypotension": 14.63, "product use in unapproved indication": 2.94, "renal impairment": 3.87, "stevens-johnson syndrome": 22.04, "toxicity to various agents": 2.82, "weight increased": 2.11}
|
||||
@@ -1 +1 @@
|
||||
{"alanine aminotransferase increased": 11.58, "anaemia": 2.14, "aspartate aminotransferase increased": 10.8, "blood bilirubin increased": 10.23, "diarrhoea": 5.77, "disease progression": 11.11, "drug-induced liver injury": 12.73, "hepatic enzyme increased": 7.3, "hepatic function abnormal": 10.18, "hepatotoxicity": 53.44, "liver disorder": 7.99, "liver function test increased": 19.96, "lung adenocarcinoma": 139.46, "lung neoplasm maligt": 5.73, "non-small cell lung cancer": 839.51, "non-small cell lung cancer metastatic": 2514.55, "off label use": 2.27, "pneumonia": 2.03, "therapy partial responder": 89.47}
|
||||
{"aggression": 3.19, "agitation": 2.81, "anxiety": 8.05, "blood pressure increased": 9.02, "completed suicide": 16.7, "depersonalisation/derealisation disorder": 52.33, "depressed mood": 3.73, "depression": 12.82, "derealisation": 134.11, "diplopia": 7.08, "dissociation": 1267.53, "dissociative disorder": 621.92, "dizziness": 2.31, "drug ineffective": 2.21, "dysarthria": 2.88, "dysgeusia": 6.23, "euphoric mood": 59.1, "fear": 13.15, "feeling abnormal": 6.27, "feeling drunk": 36.13, "hallucination": 8.24, "hallucination, auditory": 12.96, "hallucination, visual": 17.01, "hyperacusis": 14.94, "hypersomnia": 4.88, "hypertension": 3.67, "hypoaesthesia": 2.12, "hypoaesthesia oral": 5.32, "illusion": 37.87, "intentional self-injury": 19.88, "major depression": 44.23, "mania": 10.24, "nasal discomfort": 23.08, "off label use": 2.57, "panic attack": 11.34, "product dose omission issue": 4.89, "psychotic disorder": 4.73, "sedation": 77.51, "sensory disturbance": 5.02, "somnolence": 4.55, "speech disorder": 5.58, "suicidal ideation": 41.69, "suicide attempt": 23.18, "therapeutic product effect decreased": 7.1, "therapeutic response unexpected": 5.54, "throat irritation": 3.28, "underdose": 5.42, "withdrawal syndrome": 7.76}
|
||||
@@ -1 +1 @@
|
||||
{"bradycardia": 4.67, "dyspnoea": 2.31, "hypotension": 4.28, "oxygen saturation decreased": 14.79}
|
||||
{"acne": 2.79, "acute lymphocytic leukaemia recurrent": 13.28, "acute pulmonary oedema": 6.11, "adverse event": 15.97, "anaemia": 2.81, "ascites": 3.23, "aspiration pleural cavity": 225.11, "atelectasis": 2.37, "atrial fibrillation": 2.24, "back disorder": 3.43, "blast cell crisis": 93.09, "blast cell proliferation": 206.69, "blast crisis in myelogenous leukaemia": 31.32, "blood disorder": 5.95, "blood test abnormal": 2.25, "bone marrow disorder": 26.84, "bone marrow failure": 4.52, "bone marrow transplant": 44.18, "cardiac disorder": 3.16, "cardiac failure": 4.24, "cardiac failure congestive": 4.04, "cardiomegaly": 2.78, "chronic myeloid leukaemia": 24.6, "chronic myeloid leukaemia recurrent": 59.96, "chronic myeloid leukaemia transformation": 41.0, "chylothorax": 288.77, "clostridium difficile colitis": 2.18, "clostridium difficile infection": 3.2, "colitis": 5.49, "cytomegalovirus enterocolitis": 16.97, "cytopenia": 14.51, "death": 3.25, "drug intolerance": 2.35, "drug resistance": 2.8, "dyspnoea exertional": 2.2, "electrocardiogram qt prolonged": 5.47, "enterocolitis": 4.26, "enterocolitis haemorrhagic": 24.75, "fluid retention": 16.18, "full blood count decreased": 14.83, "gallbladder disorder": 3.49, "gastric ulcer": 2.0, "gastrointestinal disorder": 2.32, "gastrointestinal haemorrhage": 3.25, "gastrointestinal infection": 4.08, "gene mutation": 27.93, "generalised oedema": 3.6, "graft versus host disease": 4.16, "haematochezia": 2.11, "haematotoxicity": 3.4, "haemorrhage": 2.16, "haemorrhoids": 2.2, "haemothorax": 11.65, "hospitalisation": 13.24, "infection": 2.08, "intentional product use issue": 5.46, "internal haemorrhage": 3.63, "intestinal haemorrhage": 2.86, "iron deficiency anaemia": 2.8, "laboratory test abnormal": 2.46, "leukaemia": 12.14, "leukaemia recurrent": 11.47, "leukocytosis": 2.2, "leukopenia": 2.21, "lower gastrointestinal haemorrhage": 2.71, "lung disorder": 2.56, "lung infiltration": 5.43, "lymphocytosis": 10.47, "malignant neoplasm progression": 8.92, "nephrotic syndrome": 4.23, "neuropathy peripheral": 3.15, "neutropenia": 2.05, "oedema": 3.15, "oedema peripheral": 2.15, "pancytopenia": 6.71, "pericardial effusion": 34.2, "peripheral arterial occlusive disease": 2.94, "philadelphia chromosome positive": 157.93, "platelet count decreased": 3.09, "platelet count increased": 3.66, "pleural effusion": 111.06, "pleurisy": 15.28, "pneumonia": 4.1, "pneumonia fungal": 4.36, "pneumothorax": 2.35, "prescribed underdose": 50.1, "pulmonary alveolar haemorrhage": 3.04, "pulmonary arterial hypertension": 28.27, "pulmonary congestion": 2.62, "pulmonary hypertension": 36.69, "pulmonary oedema": 46.11, "red blood cell count decreased": 3.71, "respiratory failure": 2.04, "respiratory tract congestion": 4.63, "retinal haemorrhage": 2.18, "right ventricular failure": 3.55, "skin cancer": 2.42, "splenomegaly": 4.95, "stem cell transplant": 26.12, "subdural haematoma": 3.74, "therapeutic response decreased": 5.32, "therapy non-responder": 5.58, "thrombocytopenia": 4.09, "tooth disorder": 2.33, "transfusion": 8.47, "transplant": 8.05, "treatment noncompliance": 2.22, "tumour lysis syndrome": 3.06, "weight increased": 2.04, "white blood cell count abnormal": 3.62, "white blood cell count decreased": 2.39, "white blood cell count increased": 4.38}
|
||||
@@ -1 +1 @@
|
||||
{"anaemia": 8.54, "ascites": 10.34, "blood bilirubin increased": 6.84, "cerebral haemorrhage": 2.1, "cerebral infarction": 2.85, "depression": 2.08, "drug ineffective": 11.44, "haematemesis": 2.58, "haemoglobin decreased": 7.55, "haemolytic anaemia": 8.24, "hepatic cancer": 3.96, "hepatic cancer recurrent": 701.96, "hepatic cirrhosis": 26.6, "hepatic encephalopathy": 32.04, "hepatic failure": 5.77, "hepatitis": 3.13, "hepatitis b reactivation": 23.49, "hepatitis c": 206.85, "hepatitis c rna positive": 266.32, "hepatocellular carcinoma": 78.3, "hyperbilirubinaemia": 18.12, "jaundice": 6.41, "multiple organ dysfunction syndrome": 2.93, "oesophageal varices haemorrhage": 41.75, "pancreatitis acute": 2.4, "renal impairment": 4.02, "septic shock": 3.08, "treatment failure": 30.55, "treatment noncompliance": 3.44, "viral load increased": 35.38, "virologic failure": 31.91}
|
||||
{"drug interaction": 35.09}
|
||||
@@ -1 +1 @@
|
||||
{"drug ineffective": 6.03}
|
||||
{"abnormal behaviour": 4.37, "aggression": 5.73, "agitation": 5.37, "akinesia": 89.52, "aspiration": 8.94, "blood creatine phosphokinase increased": 2.93, "choking": 10.27, "chromaturia": 30.68, "colitis microscopic": 27.76, "confusional state": 5.39, "dehydration": 2.45, "delirium": 6.65, "delusion": 8.54, "dementia": 6.7, "depressed level of consciousness": 2.67, "depression": 2.45, "disease progression": 3.25, "disorientation": 4.64, "dopamine dysregulation syndrome": 201.18, "drug dependence": 3.51, "dyskinesia": 40.52, "dysphagia": 24.99, "dysstasia": 5.82, "dystonia": 15.0, "fall": 4.85, "feeding disorder": 2.94, "feeling abnormal": 2.25, "femur fracture": 3.94, "fracture": 9.06, "freezing phenomenon": 65.0, "gait disturbance": 4.04, "gait inability": 4.61, "general physical health deterioration": 3.68, "hallucination": 17.82, "hallucination, auditory": 5.28, "hallucination, visual": 25.82, "head injury": 2.51, "hip fracture": 4.68, "hypersexuality": 58.46, "hypokinesia": 12.21, "ileus": 9.05, "incorrect dose administered": 3.6, "medication error": 3.77, "movement disorder": 6.39, "muscle rigidity": 23.25, "musculoskeletal stiffness": 3.3, "nervousness": 3.97, "neuroleptic malignant syndrome": 6.34, "nightmare": 2.49, "on and off phenomenon": 232.43, "oral mucosal discolouration": 162.21, "orthostatic hypotension": 11.08, "overdose": 2.49, "paralysis": 4.08, "paranoia": 11.33, "parkinson's disease": 248.91, "parkinsonian crisis": 1503.15, "parkinsonism": 14.6, "pneumonia aspiration": 9.78, "product administration error": 2.53, "product complaint": 60.37, "product prescribing error": 9.21, "product quality issue": 4.34, "product residue present": 25.8, "product size issue": 33.8, "product supply issue": 62.3, "product use complaint": 21.15, "psychomotor hyperactivity": 11.66, "psychotic disorder": 6.09, "respiratory arrest": 3.53, "rhabdomyolysis": 5.83, "salivary hypersecretion": 8.39, "somnolence": 2.09, "speech disorder": 5.69, "suicide attempt": 3.1, "therapeutic product effect decreased": 3.84, "therapeutic response shortened": 32.94, "therapy cessation": 9.55, "tremor": 4.64, "urinary tract infection": 2.11, "weight decreased": 2.55, "wrong technique in product usage process": 24.26}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"acute respiratory failure": 15.71, "apnoea": 6.66, "aspiration": 35.31, "atelectasis": 36.77, "back pain": 3.73, "brain injury": 7.11, "bronchial secretion retention": 96.28, "bronchiolitis": 16.42, "bronchitis": 3.47, "cardiac arrest": 4.71, "cardio-respiratory arrest": 8.32, "cerebrospinal fluid leakage": 158.68, "choking": 4.72, "chronic respiratory failure": 74.52, "csf pressure increased": 692.88, "csf protein increased": 106.38, "death": 2.57, "dehydration": 2.5, "device dislocation": 17.6, "dysphagia": 3.39, "enterovirus infection": 164.53, "femur fracture": 16.82, "gait inability": 6.53, "gastrointestinal infection": 16.5, "general physical health deterioration": 2.04, "hip fracture": 4.03, "hydrocephalus": 33.58, "hypoxia": 2.46, "increased bronchial secretion": 28.98, "infection": 3.62, "intracranial pressure increased": 21.2, "joint dislocation": 23.06, "lower limb fracture": 6.92, "lower respiratory tract infection": 2.22, "malnutrition": 16.18, "meningitis": 8.3, "meningitis aseptic": 12.38, "mobility decreased": 3.27, "motor dysfunction": 16.26, "muscle contracture": 18.98, "muscular weakness": 2.23, "nasopharyngitis": 2.09, "nephrolithiasis": 5.78, "neurological examination abnormal": 176.02, "neurological procedural complication": 1482.7, "oxygen saturation decreased": 4.68, "parainfluenzae virus infection": 60.09, "pneumonia": 7.73, "pneumonia aspiration": 7.12, "pneumonia viral": 23.04, "pneumothorax": 10.89, "post lumbar puncture syndrome": 5873.49, "post procedural complication": 52.93, "post procedural infection": 20.9, "prescribed underdose": 6.59, "procedural complication": 66.4, "procedural nausea": 215.64, "procedural pain": 267.89, "procedural vomiting": 240.53, "proteinuria": 7.34, "respiratory arrest": 8.01, "respiratory disorder": 20.2, "respiratory distress": 6.31, "respiratory failure": 9.49, "respiratory syncytial virus infection": 37.99, "respiratory tract infection": 30.68, "respiratory tract infection viral": 40.34, "rhinovirus infection": 220.49, "sars-cov-2 test positive": 3.63, "scoliosis": 404.29, "sepsis": 2.93, "spinal deformity": 60.92, "spinal muscular atrophy": 2608.81, "therapeutic product effect decreased": 3.63, "traumatic lumbar puncture": 1620.09, "upper respiratory tract infection": 5.26, "viral infection": 11.64}
|
||||
{"lactic acidosis": 204.17}
|
||||
@@ -1 +1 @@
|
||||
{"acute kidney injury": 11.15, "asthenia": 3.88, "atrial fibrillation": 2.23, "blood creatinine increased": 3.87, "blood potassium increased": 13.98, "bradycardia": 3.8, "dehydration": 4.11, "drug interaction": 3.02, "drug reaction with eosinophilia and systemic symptoms": 11.97, "gynaecomastia": 37.53, "hyperkalaemia": 81.25, "hypokalaemia": 4.21, "hyponatraemia": 11.7, "hypotension": 5.26, "intermenstrual bleeding": 2.31, "metabolic acidosis": 7.21, "oedema peripheral": 3.09, "orthostatic hypotension": 9.46, "product use in unapproved indication": 2.08, "renal impairment": 3.63, "stevens-johnson syndrome": 11.59}
|
||||
{"death": 5.31}
|
||||
@@ -1 +1 @@
|
||||
{"anxiety": 6.57, "blood pressure increased": 8.1, "completed suicide": 6.98, "depersonalisation/derealisation disorder": 30.37, "depressed mood": 3.27, "depression": 10.31, "derealisation": 97.54, "diplopia": 6.82, "dissociation": 946.73, "dissociative disorder": 391.8, "dizziness": 2.53, "drug ineffective": 2.11, "dysarthria": 2.23, "dysgeusia": 5.89, "euphoric mood": 35.11, "fear": 8.84, "feeling abnormal": 5.81, "feeling drunk": 29.6, "hallucination": 5.67, "hallucination, auditory": 9.44, "hallucination, visual": 11.17, "hyperacusis": 16.35, "hypersomnia": 5.18, "hypertension": 3.68, "hypoaesthesia": 2.46, "hypoaesthesia oral": 5.07, "illusion": 30.52, "intentional self-injury": 5.85, "major depression": 33.98, "mania": 5.52, "nasal discomfort": 15.86, "off label use": 2.58, "panic attack": 9.05, "product dose omission issue": 4.34, "psychotic disorder": 3.36, "sedation": 56.2, "sensory disturbance": 5.81, "somnolence": 3.76, "speech disorder": 4.29, "suicidal ideation": 30.48, "suicide attempt": 12.03, "therapeutic product effect decreased": 6.56, "therapeutic response unexpected": 3.75, "throat irritation": 2.32, "underdose": 4.57, "withdrawal syndrome": 2.93}
|
||||
{"diabetic ketoacidosis": 41.96, "fournier's gangrene": 144.4, "urinary tract infection": 9.18}
|
||||
@@ -1 +1 @@
|
||||
{"acne": 2.47, "acute lymphocytic leukaemia recurrent": 18.5, "acute pulmonary oedema": 5.05, "adverse event": 13.67, "anaemia": 2.89, "ascites": 3.49, "aspiration pleural cavity": 213.12, "atelectasis": 2.28, "atrial fibrillation": 2.2, "back disorder": 2.84, "blast cell crisis": 125.68, "blast cell proliferation": 214.98, "blast crisis in myelogenous leukaemia": 43.5, "blood disorder": 5.71, "blood test abnormal": 2.42, "bone marrow disorder": 28.36, "bone marrow failure": 4.45, "bone marrow transplant": 49.95, "bone pain": 2.44, "cardiac disorder": 3.04, "cardiac failure": 4.31, "cardiac failure congestive": 4.41, "cardiomegaly": 2.39, "chronic myeloid leukaemia": 29.76, "chronic myeloid leukaemia recurrent": 84.9, "chronic myeloid leukaemia transformation": 59.06, "chylothorax": 279.52, "clostridium difficile infection": 2.64, "colitis": 6.27, "cytomegalovirus enterocolitis": 18.91, "cytomegalovirus infection": 2.27, "cytopenia": 16.17, "death": 3.14, "drug intolerance": 2.3, "drug resistance": 3.29, "dyspnoea exertional": 2.47, "electrocardiogram qt prolonged": 3.52, "enterocolitis": 4.18, "enterocolitis haemorrhagic": 17.15, "fluid retention": 15.1, "folliculitis": 2.1, "full blood count decreased": 12.53, "gallbladder disorder": 2.98, "gastrointestinal disorder": 2.19, "gastrointestinal haemorrhage": 3.29, "gastrointestinal infection": 4.06, "gene mutation": 33.99, "generalised oedema": 3.02, "graft versus host disease": 4.67, "haematochezia": 2.22, "haematotoxicity": 4.07, "haemorrhage": 2.03, "haemothorax": 9.86, "hospitalisation": 12.68, "infection": 2.21, "intentional product use issue": 4.92, "internal haemorrhage": 4.04, "intestinal haemorrhage": 2.78, "iron deficiency anaemia": 2.71, "laboratory test abnormal": 2.24, "leukaemia": 8.27, "leukaemia recurrent": 14.62, "lower gastrointestinal haemorrhage": 2.91, "lung disorder": 2.41, "lung infiltration": 4.75, "lymphocytosis": 9.05, "maligt neoplasm progression": 11.76, "nephrotic syndrome": 4.33, "neuropathy peripheral": 2.93, "neutropenia": 2.1, "oedema": 2.78, "pancytopenia": 6.25, "pericardial effusion": 38.98, "peripheral arterial occlusive disease": 3.55, "philadelphia chromosome positive": 212.22, "platelet count decreased": 3.08, "platelet count increased": 3.69, "pleural effusion": 118.79, "pleurisy": 14.87, "pneumonia": 3.81, "pneumonia fungal": 4.89, "pneumothorax": 2.19, "prescribed underdose": 60.17, "pulmonary alveolar haemorrhage": 2.87, "pulmonary arterial hypertension": 32.61, "pulmonary congestion": 2.23, "pulmonary hypertension": 37.57, "pulmonary oedema": 39.37, "red blood cell count decreased": 3.56, "respiratory tract congestion": 4.6, "retinal haemorrhage": 2.44, "right ventricular failure": 3.62, "splenomegaly": 4.84, "stem cell transplant": 27.73, "subdural haematoma": 3.08, "therapeutic response decreased": 5.15, "therapy non-responder": 5.4, "thrombocytopenia": 3.85, "tooth disorder": 2.29, "transfusion": 9.24, "transplant": 8.94, "tumour lysis syndrome": 3.5, "white blood cell count abnormal": 4.03, "white blood cell count decreased": 2.18, "white blood cell count increased": 3.82}
|
||||
{"genital infection fungal": 578.63, "urinary tract infection": 23.75}
|
||||
@@ -1 +1 @@
|
||||
{"acute kidney injury": 2.12, "adrenal insufficiency": 10.45, "alanine aminotransferase increased": 4.65, "aspartate aminotransferase increased": 3.94, "blood bilirubin increased": 2.4, "blood pressure increased": 2.68, "blood thyroid stimulating hormone increased": 13.61, "colitis": 2.94, "decreased appetite": 2.97, "dehydration": 2.03, "diarrhoea": 4.82, "disease progression": 6.32, "drug-induced liver injury": 4.74, "dysphonia": 13.08, "general physical health deterioration": 3.66, "hepatic function abnormal": 4.47, "hepatitis": 14.32, "hepatotoxicity": 13.58, "hyperkalaemia": 2.24, "hypertension": 10.5, "hyperthyroidism": 5.62, "hypertransaminasaemia": 10.21, "hypothyroidism": 31.07, "immune-mediated hepatic disorder": 64.52, "immune-mediated hypothyroidism": 51.1, "immune-mediated myocarditis": 35.77, "liver disorder": 2.69, "liver function test increased": 3.78, "maligt neoplasm progression": 14.87, "metastatic renal cell carcinoma": 26.6, "mucosal inflammation": 10.61, "neoplasm progression": 31.69, "off label use": 2.51, "osteonecrosis of jaw": 12.5, "palmar-plantar erythrodysaesthesia syndrome": 31.0, "pancreatitis acute": 2.45, "pneumonitis": 3.46, "polycythaemia": 43.29, "posterior reversible encephalopathy syndrome": 23.69, "product use in unapproved indication": 2.36, "proteinuria": 11.88, "stomatitis": 5.74, "therapy partial responder": 32.64, "thyroiditis": 17.0, "transaminases increased": 5.58, "tubulointerstitial nephritis": 6.25, "weight decreased": 3.12}
|
||||
{"confusional state": 7.5, "restlessness": 22.62, "somnolence": 5.36}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"abnormal behaviour": 2.9, "aggression": 3.51, "agitation": 3.51, "akinesia": 60.66, "aspiration": 6.78, "blood creatine phosphokinase increased": 2.01, "choking": 6.06, "chromaturia": 22.25, "colitis microscopic": 24.32, "confusional state": 4.22, "dehydration": 2.21, "delirium": 4.73, "delusion": 6.04, "dementia": 5.82, "disease progression": 3.63, "disorientation": 3.59, "dopamine dysregulation syndrome": 201.05, "dyskinesia": 28.17, "dysphagia": 21.4, "dysstasia": 5.74, "dystonia": 8.95, "fall": 4.21, "feeding disorder": 3.06, "feeling abnormal": 2.09, "femur fracture": 3.67, "fracture": 9.76, "freezing phenomenon": 74.07, "gait disturbance": 3.85, "gait inability": 4.44, "general physical health deterioration": 3.93, "hallucination": 12.22, "hallucination, auditory": 3.85, "hallucination, visual": 16.88, "head injury": 2.23, "hip fracture": 4.12, "hypersexuality": 45.62, "hypokinesia": 12.0, "ileus": 7.42, "movement disorder": 6.43, "muscle rigidity": 16.99, "musculoskeletal stiffness": 3.75, "nervousness": 2.65, "neuroleptic maligt syndrome": 4.17, "on and off phenomenon": 220.32, "oral mucosal discolouration": 81.06, "orthostatic hypotension": 7.16, "paralysis": 3.97, "paranoia": 7.66, "parkinson's disease": 204.52, "parkinsonian crisis": 804.44, "parkinsonism": 8.38, "pneumonia aspiration": 7.97, "product complaint": 21.73, "product prescribing error": 5.6, "product quality issue": 2.3, "product residue present": 9.74, "product size issue": 24.73, "product supply issue": 32.35, "product use complaint": 11.69, "psychomotor hyperactivity": 6.54, "psychotic disorder": 4.33, "rhabdomyolysis": 3.35, "salivary hypersecretion": 5.52, "speech disorder": 4.37, "therapeutic product effect decreased": 3.55, "therapeutic response shortened": 37.46, "therapy cessation": 7.53, "tremor": 4.1, "urinary tract infection": 2.2, "weight decreased": 2.52, "wrong technique in product usage process": 17.22}
|
||||
{"acute kidney injury": 3.93, "pneumonia": 2.02}
|
||||
@@ -1 +1 @@
|
||||
{"alanine aminotransferase increased": 5.6, "aspartate aminotransferase increased": 6.51, "blood glucose increased": 5.13, "gamma-glutamyltransferase increased": 10.48, "hypoglycaemia": 24.58}
|
||||
{"decreased appetite": 11.39}
|
||||
@@ -1 +1 @@
|
||||
{"lactic acidosis": 80.9}
|
||||
{"acute hepatic failure": 4.9, "adenocarcinoma of colon": 34.47, "adverse drug reaction": 2.18, "alanine aminotransferase increased": 6.12, "altered state of consciousness": 2.19, "ammonia increased": 12.69, "aphonia": 2.19, "ascites": 8.35, "aspartate aminotransferase increased": 8.5, "asthenia": 2.08, "bilirubin conjugated increased": 7.43, "blister": 6.76, "blood albumin decreased": 3.46, "blood alkaline phosphatase increased": 2.92, "blood bilirubin increased": 20.93, "blood lactate dehydrogenase increased": 2.75, "blood pressure increased": 2.7, "blood thyroid stimulating hormone increased": 5.49, "c-reactive protein increased": 3.65, "cancer pain": 9.52, "carbohydrate antigen 19-9 increased": 33.84, "carcinoembryonic antigen increased": 71.65, "cholangitis": 5.88, "cholecystitis": 3.2, "chromaturia": 3.76, "colon cancer": 74.29, "colon cancer metastatic": 87.06, "colon cancer recurrent": 123.84, "colorectal cancer": 487.08, "colorectal cancer metastatic": 433.83, "death": 2.37, "decreased appetite": 3.57, "dermatitis bullous": 3.21, "dermatitis exfoliative generalised": 5.18, "diarrhoea": 2.24, "disease progression": 2.04, "disseminated intravascular coagulation": 10.38, "drug eruption": 12.35, "drug-induced liver injury": 7.7, "dry skin": 2.14, "dysphonia": 16.49, "eating disorder": 2.58, "encephalopathy": 2.74, "erythema multiforme": 19.84, "faeces discoloured": 2.04, "gastrointestinal perforation": 26.34, "gastrointestinal stromal tumour": 31.7, "general physical health deterioration": 3.1, "gingival bleeding": 2.05, "hepatic cancer": 3.51, "hepatic encephalopathy": 18.54, "hepatic enzyme increased": 2.05, "hepatic failure": 10.46, "hepatic function abnormal": 16.11, "hepatitis fulminant": 12.31, "hepatocellular carcinoma": 19.84, "hepatotoxicity": 5.66, "hydronephrosis": 3.96, "hyperammonaemia": 9.82, "hyperbilirubinaemia": 11.1, "hyperkeratosis": 21.54, "hypertension": 4.99, "hyperthermia": 2.29, "hypertransaminasaemia": 2.63, "hypoalbuminaemia": 5.68, "hypocalcaemia": 3.52, "hypophagia": 2.91, "hypophosphataemia": 6.02, "hypothyroidism": 4.98, "ileus": 5.75, "intestinal obstruction": 3.76, "intestinal perforation": 4.64, "jaundice": 11.5, "liver disorder": 7.72, "liver function test abnormal": 3.23, "liver function test increased": 4.55, "liver injury": 4.65, "melaena": 2.78, "metastases to bone": 4.0, "metastases to central nervous system": 7.48, "metastases to liver": 22.93, "metastases to lung": 36.91, "metastases to lymph nodes": 12.92, "metastases to peritoneum": 21.99, "metastasis": 4.46, "mouth ulceration": 3.35, "mucosal inflammation": 9.99, "nephrotic syndrome": 3.35, "ocular icterus": 9.93, "off label use": 7.35, "oral pain": 3.48, "pain of skin": 8.02, "palmar-plantar erythrodysaesthesia syndrome": 102.96, "performance status decreased": 2.78, "peritonitis": 5.14, "plantar erythema": 46.87, "platelet count decreased": 8.34, "posterior reversible encephalopathy syndrome": 6.71, "proctalgia": 5.94, "product use in unapproved indication": 2.32, "protein urine present": 13.78, "proteinuria": 9.37, "pulmonary mass": 3.05, "rash": 2.02, "rash erythematous": 2.09, "rash maculo-papular": 5.06, "rash papular": 2.66, "rectal adenocarcinoma": 36.59, "rectal cancer": 54.98, "rectal cancer metastatic": 101.27, "rectal haemorrhage": 2.11, "renal impairment": 2.23, "skin disorder": 2.13, "skin exfoliation": 11.56, "skin fissures": 13.85, "skin induration": 12.55, "skin reaction": 2.14, "skin swelling": 6.83, "skin toxicity": 17.6, "skin ulcer": 5.09, "skin warm": 2.07, "stevens-johnson syndrome": 4.75, "stoma site haemorrhage": 45.14, "stomatitis": 7.34, "thrombocytopenia": 2.35, "toxic skin eruption": 4.07, "transaminases increased": 3.97, "tumour haemorrhage": 12.14, "tumour marker increased": 13.62, "weight decreased": 2.3, "yellow skin": 3.62}
|
||||
@@ -1 +1 @@
|
||||
{"death": 5.13}
|
||||
{"hepatic function abnormal": 13.99, "insomnia": 3.13, "liver injury": 36.35, "pregnancy": 75.27, "pruritus": 3.04, "rash": 7.75}
|
||||
@@ -1 +1 @@
|
||||
{"diabetic ketoacidosis": 54.51, "fournier's gangrene": 194.79, "urinary tract infection": 9.55}
|
||||
{"blood alkaline phosphatase increased": 39.27, "bone pain": 3.25, "condition aggravated": 4.32, "contusion": 2.8, "craniosynostosis": 2006.96, "fall": 2.17, "femur fracture": 17.61, "hypophosphatasia": 4959.83, "injection site atrophy": 190.18, "injection site bruising": 13.04, "injection site erythema": 4.17, "injection site pruritus": 3.66, "injection site reaction": 12.15, "injection site urticaria": 20.52, "lipodystrophy acquired": 107.58, "nephrocalcinosis": 408.98, "nephrolithiasis": 7.95}
|
||||
@@ -1 +1 @@
|
||||
{"genital infection fungal": 692.32, "urinary tract infection": 24.72}
|
||||
{"acute kidney injury": 6.86, "anhedonia": 77.88, "ankle fracture": 18.36, "anxiety": 13.96, "blood creatinine increased": 9.42, "blood hiv rna increased": 10.53, "bone demineralisation": 64.35, "bone density abnormal": 70.68, "bone density decreased": 75.2, "bone disorder": 12.9, "bone loss": 76.25, "cd4 lymphocytes decreased": 11.81, "chronic kidney disease": 49.43, "clavicle fracture": 9.66, "decreased activity": 9.02, "degenerative bone disease": 45.54, "dental caries": 5.38, "depression": 3.2, "drug resistance": 3.36, "dysstasia": 3.15, "economic problem": 101.0, "emotional distress": 57.29, "end stage renal disease": 14.37, "fanconi syndrome acquired": 16.21, "femur fracture": 4.23, "fibula fracture": 14.73, "foot fracture": 17.13, "fracture": 28.89, "genotype drug resistance test positive": 13.63, "glomerular filtration rate abnormal": 20.46, "glomerular filtration rate decreased": 7.06, "hand fracture": 30.71, "hip arthroplasty": 9.79, "hip fracture": 5.44, "immune reconstitution inflammatory syndrome": 6.68, "intervertebral disc degeneration": 6.8, "loss of personal independence in daily activities": 3.82, "lower limb fracture": 6.94, "multiple fractures": 67.47, "nephrolithiasis": 3.85, "nephropathy": 22.37, "nephropathy toxic": 36.4, "osteoarthritis": 4.49, "osteomalacia": 17.1, "osteonecrosis": 64.66, "osteopenia": 51.31, "osteoporosis": 51.13, "pain": 4.05, "protein total abnormal": 49.53, "protein total increased": 18.28, "protein urine present": 9.75, "proteinuria": 4.88, "quality of life decreased": 10.36, "renal disorder": 2.23, "renal failure": 22.15, "renal impairment": 7.42, "renal injury": 49.79, "renal tubular disorder": 9.47, "rib fracture": 13.86, "shoulder fracture": 8.08, "skeletal injury": 49.36, "spinal compression fracture": 7.53, "spinal fracture": 10.72, "spinal osteoarthritis": 9.01, "teeth brittle": 27.13, "tibia fracture": 10.76, "tooth disorder": 2.96, "tooth fracture": 27.6, "tooth loss": 68.76, "treatment noncompliance": 2.57, "upper limb fracture": 6.72, "viral load increased": 13.85, "viral mutation identified": 11.53, "virologic failure": 12.5, "vitamin d deficiency": 23.31, "wrist fracture": 13.9}
|
||||
@@ -1 +1 @@
|
||||
{"abdominal abscess": 6.1, "abortion spontaneous": 4.3, "abscess": 5.61, "accidental exposure to product": 6.24, "adenocarcinoma of colon": 13.46, "alopecia": 2.27, "alopecia areata": 3.33, "anal abscess": 18.79, "anal fistula": 33.18, "ankylosing spondylitis": 3.14, "arthritis": 4.02, "arthropathy": 3.02, "b-cell lymphoma": 4.14, "basal cell carcinoma": 9.09, "breast mass": 2.09, "bronchitis": 2.13, "caesarean section": 2.51, "cellulitis": 4.08, "cervical dysplasia": 4.81, "chikungunya virus infection": 43.42, "cholecystectomy": 5.34, "clostridium difficile infection": 5.84, "colectomy": 17.08, "colitis ulcerative": 25.4, "colon cancer": 3.74, "crohn's disease": 144.81, "cutaneous t-cell lymphoma": 12.77, "cutaneous vasculitis": 3.6, "dactylitis": 16.56, "decreased immune responsiveness": 2.85, "defaecation urgency": 4.29, "dermatitis exfoliative": 4.03, "dermatitis exfoliative generalised": 4.05, "device defective": 4.2, "device deployment issue": 43.11, "device issue": 4.37, "device leakage": 3.26, "diarrhoea haemorrhagic": 2.13, "dilated cardiomyopathy": 4.65, "disability": 2.11, "diverticulitis": 2.91, "drug delivery system malfunction": 5.71, "drug ineffective": 3.81, "drug level below therapeutic": 15.43, "drug level decreased": 12.82, "ear infection": 2.16, "eosinophilic pneumonia": 2.44, "erysipelas": 6.79, "erythema nodosum": 2.67, "erythrodermic psoriasis": 43.1, "exposure during pregcy": 8.2, "faecal calprotectin abnormal": 118.12, "faecal calprotectin increased": 25.6, "female genital tract fistula": 10.6, "fistula": 33.28, "frequent bowel movements": 4.65, "gastrointestinal infection": 3.35, "gastrointestinal inflammation": 2.8, "gingivitis": 2.25, "guttate psoriasis": 29.07, "haematochezia": 2.7, "hepatic cirrhosis": 3.04, "hepatic steatosis": 2.35, "hepatitis c": 2.17, "hernia": 5.44, "herpes virus infection": 3.42, "hidradenitis": 6.29, "hip arthroplasty": 3.18, "hiv infection": 6.68, "hodgkin's disease": 6.05, "hysterectomy": 5.28, "iga nephropathy": 8.33, "ileal stenosis": 35.14, "ileostomy": 19.07, "immunosuppression": 2.61, "inappropriate schedule of product administration": 6.33, "incorrect route of product administration": 2.26, "infection": 2.32, "inflammatory bowel disease": 11.81, "infusion related reaction": 11.94, "intestinal obstruction": 7.54, "intestinal operation": 30.27, "intestinal perforation": 2.92, "intestinal resection": 33.07, "intestinal stenosis": 92.29, "invasive ductal breast carcinoma": 2.87, "iron deficiency anaemia": 2.41, "kidney infection": 2.65, "knee arthroplasty": 4.38, "knee operation": 4.96, "large intestinal stenosis": 17.93, "latent tuberculosis": 58.89, "lipoma": 5.7, "liquid product physical issue": 3.89, "loss of therapeutic response": 44.65, "lower respiratory tract infection": 5.44, "lung adenocarcinoma": 8.29, "lupus-like syndrome": 6.76, "lymphoma": 3.66, "maligt melanoma": 9.08, "maligt melanoma in situ": 7.97, "malnutrition": 2.05, "mycobacterium tuberculosis complex test positive": 56.22, "myocardial infarction": 2.43, "needle issue": 13.41, "nephrolithiasis": 3.13, "non-hodgkin's lymphoma": 2.02, "off label use": 6.37, "osteomyelitis": 2.36, "papilloma viral infection": 6.25, "paternal exposure during pregcy": 18.95, "pemphigoid": 2.04, "periodontitis": 6.32, "pharyngitis": 2.04, "pneumonia": 2.08, "poor quality product administered": 3.23, "posterior reversible encephalopathy syndrome": 3.92, "premature labour": 3.54, "product dose omission issue": 8.97, "product label issue": 5.73, "product leakage": 2.59, "product packaging issue": 4.75, "product storage error": 7.74, "product use in unapproved indication": 2.59, "product use issue": 11.8, "psoriasis": 49.94, "psoriasis area severity index increased": 68.37, "psoriatic arthropathy": 49.83, "pustular psoriasis": 41.59, "pyoderma gangrenosum": 14.17, "rash pustular": 2.55, "rectal abscess": 34.08, "rectal cancer": 8.27, "respiratory tract infection": 3.53, "sacroiliitis": 9.58, "sarcoidosis": 4.39, "sinusitis": 2.11, "skin cancer": 2.18, "skin exfoliation": 2.09, "skin infection": 3.18, "skin plaque": 2.56, "small intestinal obstruction": 7.03, "spinal operation": 2.99, "squamous cell carcinoma": 11.37, "squamous cell carcinoma of skin": 4.39, "staphylococcal infection": 4.84, "streptococcal infection": 5.05, "subcutaneous abscess": 4.17, "surgery": 7.67, "syringe issue": 45.78, "therapeutic product effect decreased": 7.72, "therapeutic product effect incomplete": 2.08, "therapeutic product ineffective": 4.38, "therapeutic response decreased": 16.51, "therapeutic response shortened": 4.07, "therapy non-responder": 5.9, "tonsillitis": 2.99, "tooth abscess": 9.32, "tooth infection": 5.53, "transitional cell carcinoma": 12.99, "treatment noncompliance": 2.24, "tuberculin test positive": 82.34, "tuberculosis": 12.5, "underdose": 2.36, "upper respiratory tract infection": 4.35, "viral infection": 2.95, "vitiligo": 8.3, "weight increased": 2.02}
|
||||
{"abnormal behaviour": 2.38, "abortion induced": 10.78, "abortion spontaneous": 14.03, "accident": 6.03, "accidental exposure to product": 10.34, "accidental exposure to product by child": 174.09, "accidental overdose": 7.32, "adverse event": 5.21, "affective disorder": 3.24, "agitation": 2.37, "alcohol abuse": 96.25, "anger": 3.05, "ankle fracture": 4.3, "anxiety": 3.21, "arthropathy": 2.55, "attention deficit hyperactivity disorder": 10.73, "back disorder": 6.71, "back injury": 5.58, "behaviour disorder": 2.8, "bipolar disorder": 4.24, "brain injury": 5.94, "coma": 2.12, "completed suicide": 4.97, "concussion": 4.4, "craniofacial fracture": 8.44, "delusion": 2.19, "dental caries": 20.37, "dependence": 24.9, "depression": 4.05, "detoxification": 189.69, "developmental delay": 13.27, "disability": 6.84, "drug abuse": 48.11, "drug dependence": 76.38, "drug detoxification": 866.78, "drug diversion": 179.97, "drug effect less than expected": 12.11, "drug ineffective for unapproved indication": 3.86, "drug screen negative": 222.08, "drug screen positive": 51.84, "drug withdrawal syndrome": 89.54, "drug withdrawal syndrome neonatal": 339.3, "endocarditis": 8.15, "euphoric mood": 31.48, "exposure during pregnancy": 17.72, "exposure via breast milk": 38.97, "extra dose administered": 3.07, "fall": 2.14, "fear": 2.42, "feeling abnormal": 2.93, "feeling of body temperature change": 3.86, "foetal distress syndrome": 10.81, "foetal exposure during pregnancy": 52.58, "foetal exposure via father": 92.28, "foetal growth restriction": 8.86, "foot fracture": 4.21, "formication": 2.57, "gallbladder disorder": 7.25, "gestational diabetes": 7.7, "gun shot wound": 67.61, "hallucination": 4.54, "hallucination, auditory": 5.57, "hallucination, visual": 4.3, "hand fracture": 4.98, "head injury": 2.82, "hepatic cirrhosis": 2.12, "hepatitis c": 7.5, "homicidal ideation": 8.3, "homicide": 45.73, "hospitalisation": 5.59, "impaired driving ability": 10.91, "inappropriate schedule of product administration": 4.2, "inappropriate schedule of product discontinuation": 223.65, "incorrect route of product administration": 2.7, "infantile diarrhoea": 75.17, "injury": 2.29, "insomnia": 2.59, "intentional overdose": 2.83, "intentional product misuse": 13.84, "intentional product use issue": 7.38, "intentional underdose": 348.09, "intervertebral disc degeneration": 3.35, "intervertebral disc protrusion": 3.88, "irritability": 2.48, "jaundice neonatal": 74.9, "joint injury": 4.8, "learning disability": 25.07, "libido decreased": 5.69, "limb injury": 3.14, "loss of consciousness": 2.86, "low birth weight baby": 26.84, "lower limb fracture": 4.28, "major depression": 4.02, "maternal exposure during pregnancy": 12.11, "mental disorder": 4.98, "mental impairment": 2.59, "miosis": 14.55, "neonatal disorder": 79.25, "nerve compression": 4.47, "no adverse event": 2.64, "oral administration complication": 170.72, "overdose": 17.49, "panic attack": 3.42, "paranoia": 10.83, "pharyngeal swelling": 4.38, "poor feeding infant": 14.72, "post-traumatic stress disorder": 6.32, "pre-eclampsia": 11.43, "premature baby": 17.86, "premature delivery": 37.49, "premature labour": 30.34, "premature rupture of membranes": 9.04, "premature separation of placenta": 19.23, "prescribed overdose": 5.93, "procedural pain": 33.53, "product dispensing error": 2.26, "product preparation issue": 532.36, "product prescribing error": 2.92, "product use issue": 4.87, "psychomotor hyperactivity": 7.09, "psychotic disorder": 3.49, "respiratory arrest": 3.51, "respiratory depression": 18.6, "restless legs syndrome": 2.45, "restlessness": 2.67, "rib fracture": 7.74, "road traffic accident": 22.26, "seizure": 3.71, "selective eating disorder": 27.9, "serotonin syndrome": 2.66, "skin laceration": 3.31, "sleep apnoea syndrome": 4.18, "small for dates baby": 13.99, "sneezing": 2.86, "spinal fracture": 4.15, "staphylococcal infection": 2.24, "stillbirth": 7.77, "substance abuse": 351.72, "substance use disorder": 16.88, "suicidal ideation": 8.04, "suicide attempt": 2.47, "swollen tongue": 2.73, "therapeutic product ineffective": 19.59, "therapeutic response unexpected": 6.64, "therapy interrupted": 14.2, "therapy naive": 236.62, "tooth disorder": 5.63, "tooth fracture": 5.73, "toothache": 2.16, "toxicity to various agents": 12.11, "tremor neonatal": 157.93, "underdose": 14.07, "unevaluable event": 3.71, "unresponsive to stimuli": 4.44, "upper limb fracture": 6.04, "uterine disorder": 20.1, "withdrawal syndrome": 16.97, "wrist fracture": 4.35, "wrong technique in product usage process": 10.79, "yawning": 9.24}
|
||||
@@ -1 +1 @@
|
||||
{"acute kidney injury": 2.8}
|
||||
{"amnesia": 91.65, "anxiety": 3.73, "chemical submission": 105189.08, "drug abuse": 287.61, "injection": 8749.34, "somnolence": 4.55, "vomiting": 2.31}
|
||||
@@ -1 +1 @@
|
||||
{"decreased appetite": 12.22}
|
||||
{"anaesthetic complication": 300.6, "anaesthetic complication neurological": 2279.13, "anaphylactic reaction": 17.94, "anaphylactic shock": 255.61, "anaphylactoid reaction": 25.38, "anaphylactoid shock": 523.77, "blood pressure decreased": 4.69, "bradycardia": 11.99, "bronchospasm": 99.75, "cardiac arrest": 17.35, "cardio-respiratory arrest": 16.02, "circulatory collapse": 16.68, "drug interaction": 2.32, "erythema": 6.11, "exposure during pregnancy": 6.03, "horner's syndrome": 207.74, "hypersensitivity": 2.06, "hyperthermia malignant": 362.5, "hypotension": 21.72, "maternal exposure during delivery": 380.96, "maternal exposure during pregnancy": 4.33, "overdose": 3.35, "oxygen saturation decreased": 4.42, "postoperative delirium": 896.28, "rash": 2.2, "rash maculo-papular": 6.27, "respiratory depression": 77.7, "shock": 24.64, "tachycardia": 5.2, "type i hypersensitivity": 70.65, "urticaria": 3.94, "withdrawal syndrome": 11.2}
|
||||
@@ -1 +1 @@
|
||||
{"confusional state": 5.88, "dizziness": 2.06, "restlessness": 17.26, "somnolence": 4.43}
|
||||
{"hyperbilirubinaemia": 109.96, "off label use": 15.71, "periorbital oedema": 365.61}
|
||||
@@ -1 +1 @@
|
||||
{"acute hepatic failure": 3.2, "adenocarcinoma of colon": 36.1, "alanine aminotransferase increased": 5.24, "ammonia increased": 8.75, "aphonia": 2.07, "ascites": 9.0, "aspartate aminotransferase increased": 7.05, "asthenia": 2.35, "bilirubin conjugated increased": 5.81, "blister": 5.55, "blood albumin decreased": 3.43, "blood alkaline phosphatase increased": 2.2, "blood bilirubin increased": 18.71, "blood lactate dehydrogenase increased": 2.21, "blood pressure increased": 2.43, "blood thyroid stimulating hormone increased": 5.41, "c-reactive protein increased": 3.66, "cancer pain": 12.0, "carbohydrate antigen 19-9 increased": 38.22, "carcinoembryonic antigen increased": 87.89, "cholangitis": 6.14, "cholecystitis": 3.21, "chromaturia": 2.75, "colon cancer": 44.07, "colon cancer metastatic": 85.18, "colon cancer recurrent": 119.02, "colorectal cancer": 4.24, "colorectal cancer metastatic": 506.49, "death": 2.29, "decreased appetite": 3.83, "dermatitis bullous": 2.27, "dermatitis exfoliative generalised": 3.18, "diarrhoea": 2.28, "disease progression": 2.28, "disseminated intravascular coagulation": 8.19, "drug eruption": 7.43, "drug-induced liver injury": 5.24, "dry skin": 2.07, "dysphonia": 13.66, "eating disorder": 2.3, "erythema multiforme": 13.29, "gastrointestinal perforation": 28.53, "gastrointestinal stromal tumour": 38.67, "general physical health deterioration": 3.3, "hepatic encephalopathy": 18.26, "hepatic failure": 9.16, "hepatic function abnormal": 11.08, "hepatitis fulmit": 7.18, "hepatocellular carcinoma": 27.52, "hepatotoxicity": 5.64, "hydronephrosis": 3.85, "hyperammonaemia": 4.34, "hyperbilirubinaemia": 10.05, "hyperkeratosis": 23.59, "hypertension": 5.0, "hypertransaminasaemia": 2.56, "hypoalbuminaemia": 5.5, "hypocalcaemia": 2.79, "hypophagia": 2.81, "hypophosphataemia": 6.77, "hypothyroidism": 5.19, "ileus": 4.71, "intestinal obstruction": 3.32, "intestinal perforation": 4.77, "jaundice": 7.77, "liver disorder": 6.47, "liver function test abnormal": 2.54, "liver function test increased": 4.86, "liver injury": 3.26, "melaena": 2.43, "metastases to bone": 5.03, "metastases to central nervous system": 9.83, "metastases to liver": 27.79, "metastases to lung": 45.84, "metastases to lymph nodes": 15.83, "metastases to peritoneum": 27.29, "metastasis": 5.13, "mouth ulceration": 3.23, "mucosal inflammation": 11.14, "nephrotic syndrome": 3.44, "ocular icterus": 7.32, "off label use": 7.36, "oral pain": 2.95, "pain of skin": 9.35, "palmar-plantar erythrodysaesthesia syndrome": 138.35, "performance status decreased": 3.29, "peritonitis": 3.47, "plantar erythema": 49.13, "platelet count decreased": 8.28, "posterior reversible encephalopathy syndrome": 7.2, "proctalgia": 4.92, "protein urine present": 14.06, "proteinuria": 10.69, "pulmonary mass": 3.2, "rash maculo-papular": 2.83, "rash papular": 2.02, "rectal adenocarcinoma": 43.86, "rectal cancer": 38.9, "rectal cancer metastatic": 114.48, "renal impairment": 2.09, "skin disorder": 2.39, "skin exfoliation": 9.09, "skin fissures": 13.46, "skin induration": 10.3, "skin swelling": 5.81, "skin toxicity": 24.1, "skin ulcer": 4.97, "skin warm": 2.19, "stevens-johnson syndrome": 2.5, "stoma site haemorrhage": 45.41, "stomatitis": 7.54, "thrombocytopenia": 2.22, "toxic skin eruption": 2.52, "transaminases increased": 3.34, "tumour haemorrhage": 14.44, "tumour marker increased": 17.17, "weight decreased": 2.27, "yellow skin": 3.45}
|
||||
{"anaphylactic reaction": 76.09, "anaphylactic shock": 74.12, "bradycardia": 56.84, "bronchospasm": 99.93, "cardiac arrest": 35.79, "drug interaction": 10.76, "hypotension": 7.3, "off label use": 2.77, "recurrence of neuromuscular blockade": 2018.98}
|
||||
@@ -1 +1 @@
|
||||
{"hepatic function abnormal": 9.72, "insomnia": 3.0, "liver injury": 25.53, "pregcy": 68.06, "pruritus": 2.48, "rash": 6.91}
|
||||
{"anaphylactic shock": 108.91}
|
||||
@@ -1 +1 @@
|
||||
{"blood alkaline phosphatase increased": 29.57, "bone pain": 3.99, "condition aggravated": 4.12, "contusion": 3.09, "craniosynostosis": 293.21, "femur fracture": 16.36, "hypophosphatasia": 5775.62, "injection site atrophy": 227.68, "injection site bruising": 12.25, "injection site erythema": 5.55, "injection site pruritus": 4.91, "injection site reaction": 15.8, "injection site urticaria": 22.34, "lipodystrophy acquired": 144.96, "nephrocalcinosis": 223.29, "nephrolithiasis": 7.35}
|
||||
{"blood glucose increased": 15.64, "glycosylated haemoglobin increased": 53.16, "hypoglycaemia": 22.11, "nausea": 2.41}
|
||||
@@ -1 +1 @@
|
||||
{"acute kidney injury": 4.87, "anhedonia": 66.53, "ankle fracture": 18.26, "anxiety": 11.33, "blood creatinine increased": 8.46, "blood hiv rna increased": 14.86, "bone demineralisation": 88.61, "bone density abnormal": 96.14, "bone density decreased": 105.01, "bone disorder": 13.07, "bone loss": 108.11, "cd4 lymphocytes decreased": 15.54, "chronic kidney disease": 60.28, "clavicle fracture": 9.56, "decreased activity": 8.84, "degenerative bone disease": 60.36, "dental caries": 4.22, "depression": 2.58, "drug resistance": 3.95, "dysstasia": 3.1, "economic problem": 81.15, "emotional distress": 54.11, "end stage renal disease": 16.51, "fanconi syndrome acquired": 22.22, "femur fracture": 3.93, "fibula fracture": 14.87, "foot fracture": 17.38, "fracture": 30.88, "genotype drug resistance test positive": 19.52, "glomerular filtration rate abnormal": 26.3, "glomerular filtration rate decreased": 8.1, "hand fracture": 30.88, "hip arthroplasty": 10.16, "hip fracture": 4.78, "immune reconstitution inflammatory syndrome": 9.32, "intervertebral disc degeneration": 6.84, "loss of personal independence in daily activities": 4.04, "lower limb fracture": 6.55, "multiple fractures": 93.94, "nephrolithiasis": 3.56, "nephropathy": 22.94, "nephropathy toxic": 28.78, "osteoarthritis": 4.69, "osteomalacia": 21.68, "osteonecrosis": 86.92, "osteopenia": 65.64, "osteoporosis": 62.36, "pain": 4.69, "protein total abnormal": 66.98, "protein total increased": 18.46, "protein urine present": 9.97, "proteinuria": 5.57, "quality of life decreased": 9.63, "renal disorder": 2.07, "renal failure": 21.84, "renal impairment": 6.94, "renal injury": 68.13, "renal tubular disorder": 9.51, "rib fracture": 13.05, "shoulder fracture": 7.4, "skeletal injury": 71.01, "spinal compression fracture": 7.68, "spinal fracture": 9.78, "spinal osteoarthritis": 9.67, "teeth brittle": 28.09, "tibia fracture": 10.95, "tooth disorder": 2.91, "tooth fracture": 29.28, "tooth loss": 92.0, "treatment noncompliance": 2.23, "upper limb fracture": 6.18, "viral load increased": 19.45, "viral mutation identified": 16.65, "virologic failure": 17.11, "vitamin d deficiency": 26.55, "wrist fracture": 13.33}
|
||||
{"acute kidney injury": 3.19, "diarrhoea": 2.51, "disease progression": 12.51, "drug ineffective": 2.21, "drug interaction": 8.67, "electrocardiogram qt prolonged": 18.94, "epistaxis": 2.53, "hypertension": 8.09, "hypothyroidism": 21.97, "leukopenia": 4.81, "malignant neoplasm progression": 2.92, "mucosal inflammation": 22.19, "nephrotic syndrome": 29.98, "neutropenia": 4.77, "osteonecrosis of jaw": 60.88, "palmar-plantar erythrodysaesthesia syndrome": 23.7, "posterior reversible encephalopathy syndrome": 24.49, "proteinuria": 9.27, "stomatitis": 4.97, "thrombocytopenia": 6.87, "thrombotic microangiopathy": 37.36}
|
||||
@@ -1 +1 @@
|
||||
{"abortion induced": 7.6, "abortion spontaneous": 12.48, "accident": 4.98, "accidental exposure to product": 6.04, "accidental exposure to product by child": 44.9, "accidental overdose": 3.2, "adverse event": 4.5, "affective disorder": 2.51, "alcohol abuse": 53.01, "ankle fracture": 4.3, "anxiety": 2.62, "arthropathy": 2.72, "attention deficit hyperactivity disorder": 4.39, "back disorder": 5.55, "back injury": 4.75, "bipolar disorder": 2.91, "brain injury": 4.16, "completed suicide": 2.08, "concussion": 3.99, "craniofacial fracture": 7.57, "dental caries": 15.78, "dependence": 6.34, "depression": 3.26, "detoxification": 107.28, "developmental delay": 4.1, "disability": 4.21, "drug abuse": 14.19, "drug dependence": 19.88, "drug detoxification": 518.75, "drug diversion": 58.7, "drug effect less than expected": 9.48, "drug ineffective for unapproved indication": 2.97, "drug screen negative": 182.77, "drug screen positive": 31.7, "drug withdrawal syndrome": 64.32, "drug withdrawal syndrome neonatal": 143.52, "endocarditis": 7.76, "euphoric mood": 18.35, "exposure during pregcy": 11.66, "exposure via breast milk": 37.27, "extra dose administered": 2.52, "feeling abnormal": 2.72, "feeling of body temperature change": 4.93, "foetal distress syndrome": 6.06, "foetal exposure during pregcy": 22.16, "foetal exposure via father": 72.04, "foetal growth restriction": 6.1, "foot fracture": 4.29, "formication": 2.29, "gallbladder disorder": 6.17, "gestational diabetes": 5.89, "gun shot wound": 30.01, "hallucination": 3.12, "hallucination, auditory": 4.04, "hallucination, visual": 2.83, "hand fracture": 5.05, "head injury": 2.51, "hepatic cirrhosis": 2.17, "hepatitis c": 9.77, "homicidal ideation": 5.1, "homicide": 15.75, "hospitalisation": 5.38, "impaired driving ability": 8.1, "inappropriate schedule of product administration": 4.58, "inappropriate schedule of product discontinuation": 144.59, "infantile diarrhoea": 41.72, "insomnia": 2.48, "intentional product misuse": 7.09, "intentional product use issue": 6.65, "intentional underdose": 226.65, "intervertebral disc degeneration": 3.38, "intervertebral disc protrusion": 3.67, "irritability": 2.15, "jaundice neonatal": 57.72, "joint injury": 4.4, "learning disability": 8.56, "libido decreased": 2.36, "limb injury": 3.01, "loss of consciousness": 2.47, "low birth weight baby": 19.89, "lower limb fracture": 4.05, "major depression": 3.1, "maternal exposure during pregcy": 11.5, "mental disorder": 3.77, "mental impairment": 2.04, "miosis": 5.6, "neonatal disorder": 35.59, "nerve compression": 4.36, "no adverse event": 2.11, "oral administration complication": 61.6, "overdose": 7.59, "panic attack": 2.73, "paranoia": 7.28, "pharyngeal swelling": 3.54, "poor feeding infant": 11.73, "post-traumatic stress disorder": 4.78, "pre-eclampsia": 8.78, "premature baby": 12.98, "premature delivery": 33.96, "premature labour": 22.61, "premature rupture of membranes": 7.45, "premature separation of placenta": 9.69, "prescribed overdose": 5.1, "procedural pain": 33.3, "product preparation issue": 320.38, "product use issue": 4.4, "psychomotor hyperactivity": 3.96, "psychotic disorder": 2.47, "respiratory depression": 7.65, "restless legs syndrome": 2.11, "restlessness": 2.03, "rib fracture": 7.3, "road traffic accident": 16.97, "seizure": 2.61, "selective eating disorder": 18.1, "skin laceration": 2.89, "sleep apnoea syndrome": 3.69, "small for dates baby": 8.89, "sneezing": 2.5, "spinal fracture": 3.8, "staphylococcal infection": 2.11, "stillbirth": 5.69, "substance abuse": 147.39, "substance use disorder": 5.9, "suicidal ideation": 5.88, "swollen tongue": 2.06, "therapeutic product ineffective": 16.62, "therapeutic response unexpected": 4.47, "therapy interrupted": 12.06, "therapy naive": 197.48, "tooth disorder": 5.53, "tooth fracture": 6.12, "tooth loss": 2.34, "toothache": 2.46, "toxicity to various agents": 5.47, "tremor neonatal": 61.32, "underdose": 11.76, "unevaluable event": 3.3, "unresponsive to stimuli": 3.37, "upper limb fracture": 5.55, "uterine disorder": 14.1, "withdrawal syndrome": 6.28, "wrist fracture": 4.19, "wrong technique in product usage process": 7.65, "yawning": 7.06}
|
||||
{"anxiety": 3.44, "blood pressure increased": 3.53, "hyperhidrosis": 2.42, "hypertension": 2.06, "insomnia": 2.92, "off label use": 2.19, "palpitations": 2.63, "product administration interrupted": 431.17, "suicidal ideation": 13.38}
|
||||
@@ -1 +1 @@
|
||||
{"amnesia": 74.44, "anxiety": 3.05, "chemical submission": 25053.41, "drug abuse": 89.15, "injection": 5888.55, "somnolence": 3.76, "vomiting": 2.21}
|
||||
{"abortion induced": 94.11, "abortion spontaneous": 6.24, "anxiety": 3.01, "confusional state": 2.04, "depression": 8.0, "drug interaction": 3.81, "drug resistance": 7.88, "foetal exposure during pregnancy": 13.77, "gamma-glutamyltransferase increased": 10.79, "hallucination": 4.87, "hepatitis": 7.49, "insomnia": 2.27, "lactic acidosis": 20.16, "lipodystrophy acquired": 57.66, "maternal exposure during pregnancy": 7.08, "nervous system disorder": 11.4, "nightmare": 19.5, "pregnancy": 87.62, "psychotic disorder": 11.7, "rash": 2.16, "rash maculo-papular": 6.77, "sleep disorder": 2.83, "stevens-johnson syndrome": 11.87, "suicidal ideation": 8.62, "suicide attempt": 8.3, "vertigo": 4.17}
|
||||
File diff suppressed because one or more lines are too long
@@ -1 +1 @@
|
||||
{"anaphylactic reaction": 54.61, "anaphylactic shock": 28.21, "bradycardia": 31.76, "bronchospasm": 54.3, "cardiac arrest": 25.11, "drug interaction": 7.19, "hypotension": 5.11, "off label use": 2.78, "recurrence of neuromuscular blockade": 2367.2}
|
||||
{"adverse event": 7.13, "agitation": 5.35, "akathisia": 85.11, "anxiety": 2.55, "disorientation": 6.82, "dysarthria": 13.57, "dysgeusia": 8.58, "dyskinesia": 9.82, "dysphagia": 3.54, "extrapyramidal disorder": 107.75, "generalised tonic-clonic seizure": 8.78, "hypoaesthesia oral": 18.43, "incorrect route of product administration": 27.97, "insomnia": 2.31, "neuroleptic malignant syndrome": 77.43, "off label use": 4.3, "parkinsonism": 58.35, "product use in unapproved indication": 2.21, "restlessness": 5.61, "rhabdomyolysis": 10.63, "schizophrenia": 50.36, "sedation": 65.03, "sedation complication": 107.51, "somnolence": 3.77, "suicidal ideation": 3.7, "suicide attempt": 10.15, "urinary retention": 7.16, "weight increased": 2.78}
|
||||
@@ -1 +1 @@
|
||||
{"anaphylactic shock": 41.49}
|
||||
{"disease progression": 13.42, "off label use": 6.01}
|
||||
Some files were not shown because too many files have changed in this diff Show More
Reference in New Issue
Block a user